{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 602829, "items": [{"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T17:57:46Z", "timestamp": 1574359066743}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 4, 1]], "date-time": "2008-04-01T00:00:00Z", "timestamp": 1207008000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Optometry - Journal of the American Optometric Association"], "published-print": {"date-parts": [[2008, 4]]}, "DOI": "10.1016/j.optm.2008.01.003", "type": "journal-article", "created": {"date-parts": [[2008, 3, 21]], "date-time": "2008-03-21T15:00:46Z", "timestamp": 1206111646000}, "page": "174-175", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Botulinum toxin represents a new approach to managing diplopia cases that do not resolve"], "prefix": "10.1016", "volume": "79", "author": [{"given": "Marc B.", "family": "Taub", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Optometry - Journal of the American Optometric Association"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1529183908000298?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1529183908000298?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 30]], "date-time": "2018-12-30T21:00:29Z", "timestamp": 1546203629000}, "score": 82.12303, "issued": {"date-parts": [[2008, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2008, 4]]}, "issue": "4"}, "alternative-id": ["S1529183908000298"], "URL": "http://dx.doi.org/10.1016/j.optm.2008.01.003", "ISSN": ["1529-1839"], "issn-type": [{"value": "1529-1839", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T20:18:25Z", "timestamp": 1574799505952}, "publisher-location": "Chichester, UK", "reference-count": 55, "publisher": "John Wiley & Sons, Ltd", "isbn-type": [{"value": "9781444338256", "type": "print"}, {"value": "9781118661833", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9781118661833.ch18", "type": "book-chapter", "created": {"date-parts": [[2017, 6, 24]], "date-time": "2017-06-24T02:41:10Z", "timestamp": 1498272070000}, "page": "233-251", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Combination Therapy of Botulinum Toxin with other Nonsurgical Procedures"], "prefix": "10.1002", "author": [{"given": "Amy", "family": "Forman Taub", "sequence": "first", "affiliation": [{"name": "Director, Founder, Advanced Dermatology; Lincolnshire LLC USA"}, {"name": "Assistant Clinical Professor/Northwestern University Medical School; Chicago USA"}]}, {"given": "Lauren", "family": "Fine", "sequence": "additional", "affiliation": [{"name": "Advanced Dermatology, LLC; Associate Dermatologist & Cosmetic Fellow; Chicago USA"}, {"name": "Chicago Cosmetic Surgery and Dermatology; Associate Dermatologist; Chicago USA"}]}], "member": "311", "published-online": {"date-parts": [[2017, 6, 23]]}, "reference": [{"issue": "Suppl 1", "key": "10.1002/9781118661833.ch18-BIB0001|c18-cit-0001", "doi-asserted-by": "crossref", "first-page": "S325", "DOI": "10.1097/DSS.0000000000000548", "article-title": "Patient satisfaction and efficacy of full-facial rejuvenation using a combination of botulinum toxin type A and hyaluronic acid filler", "volume": "41", "author": "Molina", "year": "2015", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0002|c18-cit-0002", "first-page": "127", "article-title": "Primary and adjuvant use of botulinum toxin type A (BOTOX) in facial aesthetic surgery: beyond the glabella", "volume": "28", "author": "Fagien", "year": "2001", "journal-title": "Clin Plat Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0003|c18-cit-0003", "doi-asserted-by": "crossref", "first-page": "40S", "DOI": "10.1097/00006534-200310001-00007", "article-title": "Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: adjunctive use in facial aesthetic surgery", "volume": "112", "author": "Fagien", "year": "2003", "journal-title": "Plast Reconstr Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0004|c18-cit-0004", "first-page": "539", "article-title": "Deep resting glabellar rhytides responds to BoNT-A and Hylan B", "volume": "29", "author": "Carruthers", "year": "2003", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0005|c18-cit-0005", "first-page": "802", "article-title": "A prospective, randomized, parallel group study analyzing the effect of BoNT-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BoNT-A", "volume": "29", "author": "Carruthers", "year": "2003", "journal-title": "Dermatol Surg"}, {"issue": "4", "key": "10.1002/9781118661833.ch18-BIB0006|c18-cit-0006", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1111/jocd.12059", "article-title": "Treatment of forehead/glabellar rhytides\\ complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial", "volume": "12", "author": "Dubina", "year": "2013", "journal-title": "J Cosmet Dermatol"}, {"issue": "5", "key": "10.1002/9781118661833.ch18-BIB0007|c18-cit-0007", "doi-asserted-by": "crossref", "first-page": "442", "DOI": "10.1097/01.sap.0000123806.03865.4d", "article-title": "Botox and collagen for glabellar furrows: advantages of combination therapy", "volume": "52", "author": "Patel", "year": "2004", "journal-title": "Ann Plast Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0008|c18-cit-0008", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1016/j.ohc.2005.03.004", "article-title": "Combination therapies: a nonsurgical approach to oculofacial rejuvenation", "volume": "18", "author": "Bosniak", "year": "2005", "journal-title": "Opthamol Clin N Am"}, {"issue": "5S", "key": "10.1002/9781118661833.ch18-BIB0009|c18-cit-0009", "doi-asserted-by": "crossref", "first-page": "5s", "DOI": "10.1097/PRS.0b013e31816de8d0", "article-title": "Advances in facial rejuvenation:botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies-consensus recommendations", "volume": "121", "author": "Carruthers", "year": "2008", "journal-title": "Plast Reconstr Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0010|c18-cit-0010", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1080/01676830600975206", "article-title": "Combination therapies in oculofacial rejuvenation", "volume": "25", "author": "Bosniak", "year": "2006", "journal-title": "Orbit"}, {"key": "10.1002/9781118661833.ch18-BIB0011|c18-cit-0011", "doi-asserted-by": "crossref", "first-page": "3s", "DOI": "10.1097/01.prs.0000204759.76865.39", "article-title": "Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane)", "volume": "117", "author": "Matarasso", "year": "2006", "journal-title": "Plast Reconstr Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0012|c18-cit-0012", "first-page": "491", "article-title": "Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation", "volume": "28", "author": "Friedman", "year": "2002", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0013|c18-cit-0013", "doi-asserted-by": "crossref", "first-page": "928", "DOI": "10.1046/j.1365-2133.2002.04707.x", "article-title": "Arterial embolism caused by injection of hyaluronic acid (Restylane)", "volume": "146", "author": "Schanz", "year": "2002", "journal-title": "Brit J Dermatol"}, {"key": "10.1002/9781118661833.ch18-BIB0014|c18-cit-0014", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1016/0190-9622(91)70200-L", "article-title": "Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant", "volume": "25", "author": "Hanke", "year": "1991", "journal-title": "J Am Acad Dermatol"}, {"issue": "5", "key": "10.1002/9781118661833.ch18-BIB0015|c18-cit-0015", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1046/j.1524-4725.1999.08286.x", "article-title": "Raising eyebrows with botulinum toxin", "volume": "25", "author": "Huilgol", "year": "1999", "journal-title": "Dermatol Surg"}, {"issue": "11", "key": "10.1002/9781118661833.ch18-BIB0016|c18-cit-0016", "doi-asserted-by": "crossref", "first-page": "1604", "DOI": "10.2310/6350.2005.31248", "article-title": "Facial sculpting and tissue augmentation", "volume": "31", "author": "Carruthers", "year": "2005", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0017|c18-cit-0017", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1111/jocd.12082", "article-title": "Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin", "volume": "13", "author": "Beer", "year": "2014", "journal-title": "Journal of Cosmetic Dermatology"}, {"issue": "6S", "key": "10.1002/9781118661833.ch18-BIB0018|c18-cit-0018", "doi-asserted-by": "crossref", "first-page": "81s", "DOI": "10.1097/01.prs.0000248857.84859.07", "article-title": "Hyaluronic acid fillers and botulinum toxin type A: rationale for their individual and combined use for injectable facial rejuvenation", "volume": "120", "author": "Klein", "year": "2007", "journal-title": "Plast Reconstr Surg"}, {"issue": "6", "key": "10.1002/9781118661833.ch18-BIB0019|c18-cit-0019", "doi-asserted-by": "crossref", "first-page": "1784", "DOI": "10.1097/01.PRS.0000162109.07527.A8", "article-title": "Treatment of the lower third of the nose and dynamic nasal tip ptosis with Botox", "volume": "111", "author": "Dayan", "year": "2005", "journal-title": "Plast Reconstr Surg"}, {"issue": "10", "key": "10.1002/9781118661833.ch18-BIB0020|c18-cit-0020", "doi-asserted-by": "crossref", "first-page": "1097", "DOI": "10.1097/DSS.0000000000000486", "article-title": "Avoiding and treating blindness from fillers: a review of the world literature", "volume": "41", "author": "Beleznay", "year": "2015", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0021|c18-cit-0021", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1111/j.1529-8019.2006.00072.x", "article-title": "Combination therapy with BOTOX and fillers: the new rejuvenation paradigm", "volume": "19", "author": "Coleman", "year": "2006", "journal-title": "Dermatol Ther"}, {"issue": "1", "key": "10.1002/9781118661833.ch18-BIB0022|c18-cit-0022", "first-page": "36", "article-title": "The effect of incobotulinumtoxin a and dermal filler treatment on perception of age, health, and attractiveness of female faces", "volume": "7", "author": "Fink", "year": "2014", "journal-title": "J Clin Aesthet Dermatol"}, {"issue": "5", "key": "10.1002/9781118661833.ch18-BIB0023|c18-cit-0023", "doi-asserted-by": "crossref", "first-page": "586", "DOI": "10.1097/DSS.0000000000000754", "article-title": "Consensus recommendations for combined aesthetic interventions in the face using botulinum toxin, fillers, and energy-based devices", "volume": "42", "author": "Carruthers", "year": "2016", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0024|c18-cit-0024", "doi-asserted-by": "crossref", "first-page": "1179", "DOI": "10.1111/j.1524-4725.2005.31924", "article-title": "Intense pulsed light as a nonablative approach to photoaging", "volume": "31", "author": "Goldman", "year": "2005", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0025|c18-cit-0025", "doi-asserted-by": "crossref", "first-page": "196", "DOI": "10.1002/(SICI)1096-9101(2000)26:2<196::AID-LSM10>3.0.CO;2-9", "article-title": "Nonablative treatment of rhytids with intense pulsed light", "volume": "26", "author": "Goldberg", "year": "2000", "journal-title": "Lasers Surg Med"}, {"key": "10.1002/9781118661833.ch18-BIB0026|c18-cit-0026", "first-page": "1115", "article-title": "Rejuvenation of photoaged skin: 5 years results with intense pulsed light of the face, neck, and chest", "volume": "28", "author": "Weiss", "year": "2002", "journal-title": "Dermatol Surg"}, {"issue": "1", "key": "10.1002/9781118661833.ch18-BIB0027|c18-cit-0027", "first-page": "41", "article-title": "Photorejuvenation with intense pulsed light: results of a multi-center study", "volume": "3", "author": "Sadick", "year": "2004", "journal-title": "J Drugs Dermatol"}, {"issue": "8", "key": "10.1002/9781118661833.ch18-BIB0028|c18-cit-0028", "doi-asserted-by": "crossref", "first-page": "985", "DOI": "10.1001/archderm.142.8.985", "article-title": "Skin rejuvenation using intense pulsed light: a randomized controlled split-face trial with blinded response evaluation", "volume": "142", "author": "Hedelund", "year": "2006", "journal-title": "Arch Dermatol"}, {"key": "10.1002/9781118661833.ch18-BIB0029|c18-cit-0029", "first-page": "355", "article-title": "The effect of full-face broadband light treatments alone and in combination with bilateral crow's feet botulinum toxin type A chemodenervation", "volume": "30", "author": "Carruthers", "year": "2004", "journal-title": "Dermatol Surg"}, {"issue": "3", "key": "10.1002/9781118661833.ch18-BIB0030|c18-cit-0030", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1097/01.iio.0000167162.33503.ad", "article-title": "Adjunctive botulinum toxin type A; fillers and light-based therapies", "volume": "45", "author": "Carruthers", "year": "2005", "journal-title": "Int Ophthalmol Clin"}, {"key": "10.1002/9781118661833.ch18-BIB0031|c18-cit-0031", "first-page": "1062", "article-title": "The effect of botulinum toxin type a on full-face intense pulsed light treatment: a randomized, double-blind, split-face study", "volume": "34", "author": "Khoury", "year": "2008", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0032|c18-cit-0032", "doi-asserted-by": "crossref", "first-page": "399", "DOI": "10.1097/00042728-200504000-00005", "article-title": "Does laser inactivate botulinum toxin", "volume": "31", "author": "Semchyshyn", "year": "2005", "journal-title": "Dermatol Surg"}, {"issue": "Suppl 2", "key": "10.1002/9781118661833.ch18-BIB0033|c18-cit-0033", "doi-asserted-by": "crossref", "first-page": "S168", "DOI": "10.1097/DSS.0000000000000751", "article-title": "Combining microfocused ultrasound with botulinum toxin andtemporary and semi-permanent dermal fillers: safety and current use", "volume": "42", "author": "Fabi", "year": "2016", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0034|c18-cit-0034", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1016/S1064-7406(03)00071-3", "article-title": "Adjunctive applications for botulinum toxin in facial aesthetic surgery", "volume": "11", "author": "Zimbler", "year": "2003", "journal-title": "Facial Plast Surg Clin N Am"}, {"key": "10.1002/9781118661833.ch18-BIB0035|c18-cit-0035", "doi-asserted-by": "crossref", "first-page": "701", "DOI": "10.1097/00006534-199902000-00055", "article-title": "Botox for the treatment of dynamic and hyperkinetic facial lines and furrows", "volume": "103", "author": "Fagien", "year": "1999", "journal-title": "Plast Reconstr Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0036|c18-cit-0036", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1016/S1090-820X(98)70043-3", "article-title": "Extended use of botulinum toxin A in facial aesthetic surgery", "volume": "18", "author": "Fagien", "year": "1998", "journal-title": "Aesthet Surg J"}, {"key": "10.1002/9781118661833.ch18-BIB0037|c18-cit-0037", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1046/j.1524-4725.1999.08244.x", "article-title": "Effect of botulinum toxin type A on movement-associated rhytides following CO2 laser resurfacing", "volume": "25", "author": "West", "year": "1999", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0038|c18-cit-0038", "author": "Carruthers", "first-page": "235", "year": "1998", "volume-title": "Combined Therapy: BOTOX and CO2 Facial Laser Resurfacing"}, {"key": "10.1002/9781118661833.ch18-BIB0039|c18-cit-0039", "author": "Carruthers", "first-page": "315", "year": "2000", "volume-title": "Management of Facial Lines and Wrinkles"}, {"key": "10.1002/9781118661833.ch18-BIB0040|c18-cit-0040", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.1177/074880680001700302", "article-title": "The power of combined therapies: Botox and ablative facial laser resurfacing", "volume": "17", "author": "Carruthers", "year": "2000", "journal-title": "Am J Cosmet Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0041|c18-cit-0041", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1001/archfaci.3.3.165", "article-title": "Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial", "volume": "3", "author": "Zimbler", "year": "2001", "journal-title": "Arch Facial Plast Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0042|c18-cit-0042", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1080/14764170410023767", "article-title": "Botulinum toxin type A gives adjunctive benefit to periorbital laser resurfacing", "volume": "6", "author": "Yamauchi", "year": "2004", "journal-title": "J Cosmet Laser Ther"}, {"key": "10.1002/9781118661833.ch18-BIB0043|c18-cit-0043", "first-page": "1151", "article-title": "Botulinum toxin type A enhances the outcome of fractional resurfacing of the cheek", "volume": "6", "author": "Beer", "year": "2007", "journal-title": "J Drugs in Dermatol"}, {"key": "10.1002/9781118661833.ch18-BIB0044|c18-cit-0044", "unstructured": "Comstock J 2008"}, {"key": "10.1002/9781118661833.ch18-BIB0045|c18-cit-0045", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1111/j.1473-2165.2006.00237.x", "article-title": "Combination of chemical peelings with botulinum toxin injections and dermal fillers", "volume": "5", "author": "Landau", "year": "2006", "journal-title": "J Cosmet Dermatol"}, {"key": "10.1002/9781118661833.ch18-BIB0046|c18-cit-0046", "first-page": "1066", "article-title": "Botulinum toxin A adjunctive use in manual chemabrasion: controlled long-term study for treatment of upper perioral vertical wrinkles", "volume": "33", "author": "Kadunc", "year": "2007", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0047|c18-cit-0047", "unstructured": "Sadick N 2005"}, {"issue": "6", "key": "10.1002/9781118661833.ch18-BIB0048|c18-cit-0048", "doi-asserted-by": "crossref", "first-page": "602", "DOI": "10.1016/j.clindermatol.2007.09.007", "article-title": "Thermage: the noablative radiofrequency for rejuvenation", "volume": "26", "author": "Sukal", "year": "2008", "journal-title": "Clin Dermatol"}, {"issue": "2", "key": "10.1002/9781118661833.ch18-BIB0049|c18-cit-0049", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1016/j.cps.2008.11.006", "article-title": "Clinical applications of radiofrequency: nonsurgical skin tightening (thermage)", "volume": "36", "author": "Hodgkinson", "year": "2009", "journal-title": "Clin Plast Surg"}, {"issue": "2", "key": "10.1002/9781118661833.ch18-BIB0050|c18-cit-0050", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1076/otoo.4.2.113.16583", "article-title": "Thermalifting of face, neck, and brows", "volume": "4", "author": "Bosniak", "year": "2001", "journal-title": "Oper Tech Oculoplast Orbital Reconstr Surg"}, {"key": "10.1002/9781118661833.ch18-BIB0051|c18-cit-0051", "unstructured": "Mullholland , RS nd"}, {"issue": "5", "key": "10.1002/9781118661833.ch18-BIB0052|c18-cit-0052", "first-page": "360", "article-title": "Evaluation of a nonsurgical, muscle-stimulating system to elevate soft tissues of the face and neck", "volume": "5", "author": "Taub", "year": "2006", "journal-title": "J Drugs Dermatol"}, {"issue": "Suppl 2", "key": "10.1002/9781118661833.ch18-BIB0053|c18-cit-0053", "doi-asserted-by": "crossref", "first-page": "S77", "DOI": "10.1097/DSS.0000000000000740", "article-title": "Rejuvenation of the upper face and periocular region: combining neuromodulator, facial filler, laser, light, and energy-based therapies for optimal results", "volume": "42", "author": "Langelier", "year": "2016", "journal-title": "Dermatol Surg"}, {"issue": "1", "key": "10.1002/9781118661833.ch18-BIB0054|c18-cit-0054", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.3109/14764172.2014.968578", "article-title": "Are combined same-day treatments the future for photorejuvenation? Review of the literature on combined treatments with lasers, intense pulsed light, radiofrequency, botulinum toxin, and fillers for rejuvenation", "volume": "17", "author": "Cuerda-Galindo", "year": "2015", "journal-title": "J Cosmet Laser Ther"}, {"issue": "Suppl 1", "key": "10.1002/9781118661833.ch18-BIB0055|c18-cit-0055", "doi-asserted-by": "crossref", "first-page": "S325", "DOI": "10.1097/DSS.0000000000000548", "article-title": "Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler", "volume": "41", "author": "Molina", "year": "2015", "journal-title": "Dermatol Surg"}], "container-title": ["Botulinum Toxins"], "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F9781118661833.ch18", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1002/9781118661833.ch18/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 9, 18]], "date-time": "2017-09-18T11:22:00Z", "timestamp": 1505733720000}, "score": 32.23636, "issued": {"date-parts": [[2017, 6, 23]]}, "ISBN": ["9781118661833", "9781444338256"], "references-count": 55, "URL": "http://dx.doi.org/10.1002/9781118661833.ch18", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T09:32:53Z", "timestamp": 1574155973557}, "publisher-location": "Basel", "reference-count": 0, "publisher": "KARGER", "isbn-type": [{"value": "3805575009", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2003]]}, "DOI": "10.1159/000069636", "type": "book-chapter", "created": {"date-parts": [[2004, 12, 13]], "date-time": "2004-12-13T08:40:06Z", "timestamp": 1102927206000}, "page": "71-81", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Treatment of Painful Dystonia with Botulinum Toxin"], "prefix": "10.1159", "author": [{"given": "M.", "family": "Naumann", "sequence": "first", "affiliation": []}, {"given": "B.", "family": "Herting", "sequence": "additional", "affiliation": []}], "member": "127", "container-title": ["Pain and Headache", "Botulinum Toxin in Painful Diseases"], "link": [{"URL": "http://www.karger.com/Article/Pdf/69636", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 10, 25]], "date-time": "2017-10-25T14:48:23Z", "timestamp": 1508942903000}, "score": 30.07743, "issued": {"date-parts": [[2003]]}, "ISBN": ["3805575009"], "references-count": 0, "URL": "http://dx.doi.org/10.1159/000069636"}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T10:16:48Z", "timestamp": 1574763408694}, "reference-count": 10, "publisher": "SLACK, Inc.", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Pediatr Ophthalmol Strabismus"], "published-print": {"date-parts": [[2016, 3, 1]]}, "DOI": "10.3928/01913913-20160122-06", "type": "journal-article", "created": {"date-parts": [[2016, 2, 5]], "date-time": "2016-02-05T16:59:30Z", "timestamp": 1454691570000}, "page": "80-84", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Inferior Oblique Botulinum Toxin Injection: A Postoperative Diplopia Test for Secondary Inferior Oblique Muscle Overaction"], "prefix": "10.3928", "volume": "53", "author": [{"given": "Shveta", "family": "Bansal", "sequence": "first", "affiliation": []}, {"given": "Ian B.", "family": "Marsh", "sequence": "additional", "affiliation": []}], "member": "2308", "published-online": {"date-parts": [[2016, 2, 4]]}, "container-title": ["Journal of Pediatric Ophthalmology & Strabismus"], "language": "en", "link": [{"URL": "https://www.healio.com/ophthalmology/journals/jpos/2016-3-53-2/%7B008beb7c-642a-4e95-b5e5-b4fccef75030%7D/inferior-oblique-botulinum-toxin-injection-a-postoperative-diplopia-test-for-secondary-inferior-oblique-muscle-overaction", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 29]], "date-time": "2017-06-29T16:33:03Z", "timestamp": 1498753983000}, "score": 28.592247, "issued": {"date-parts": [[2016, 2, 4]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[2016, 3, 1]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.3928/01913913-20160122-06", "ISSN": ["0191-3913"], "issn-type": [{"value": "0191-3913", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T14:49:58Z", "timestamp": 1574520598300}, "publisher-location": "Berlin, Heidelberg", "reference-count": 20, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642035791", "type": "print"}, {"value": "9783642035807", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011]]}, "DOI": "10.1007/978-3-642-03580-7_6", "type": "book-chapter", "created": {"date-parts": [[2011, 6, 24]], "date-time": "2011-06-24T08:58:21Z", "timestamp": 1308905901000}, "page": "95-107", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Pediatric Botulinum Toxin Applications"], "prefix": "10.1007", "author": [{"given": "Michael B.", "family": "Chancellor", "sequence": "first", "affiliation": []}, {"given": "Christopher P.", "family": "Smith", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 5, 2]]}, "reference": [{"key": "6_CR1_6", "doi-asserted-by": "publisher", "first-page": "650", "DOI": "10.1001/jama.1984.03350050038023", "volume": "252", "author": "SB Bauer", "year": "1984", "unstructured": "Bauer SB, Hallett M, Khoshbin S et al (1984) Predictive value of urodynamic evaluation in newborns with myelodysplasia. JAMA 252:650\u2013652", "journal-title": "JAMA"}, {"key": "6_CR2_6", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1007/s11255-009-9600-7", "volume": "42", "author": "MB Chancellor", "year": "2010", "unstructured": "Chancellor MB (2010) Ten years single surgeon experience with botulinum toxin in the urinary tract; clinical observations and research discovery. Int Urol Nephrol 42:383\u2013391", "journal-title": "Int Urol Nephrol"}, {"key": "6_CR3_6", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1016/S0022-5347(18)37943-6", "volume": "171", "author": "J Corcos", "year": "2004", "unstructured": "Corcos J, Al-Taweed W, Robichaud C (2004) Botulinum toxin as an alternative treatment to bladder augmentation in children with neurogenic bladder due to myelomeningocele [abstract]. J Urol 171:181", "journal-title": "J Urol"}, {"key": "6_CR4_6", "doi-asserted-by": "publisher", "first-page": "1500", "DOI": "10.1016/S0022-5347(01)66914-3", "volume": "154", "author": "RA Edelstein", "year": "1995", "unstructured": "Edelstein RA, Bauer SB, Kelly MD et al (1995) The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol 154:1500\u20131504", "journal-title": "J Urol"}, {"key": "6_CR5_6", "doi-asserted-by": "publisher", "first-page": "328", "DOI": "10.1016/S0022-5347(06)00301-6", "volume": "176", "author": "P Hoebeke", "year": "2006", "unstructured": "Hoebeke P, De Caestecker K, Vande Walle J, Dehoorne J, Raes A, Verleyen P, Van Laecke E (2006) The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor. J Urol 176:328\u2013330; discussion 330\u2013331", "journal-title": "J Urol"}, {"key": "6_CR6_6", "first-page": "78", "volume": "84", "author": "DB Joseph", "year": "1989", "unstructured": "Joseph DB, Bauer SB, Colodny AH et al (1989) Clean, intermittent catheterization of infants with neurogenic bladder. Pediatrics 84:78\u201382", "journal-title": "Pediatrics"}, {"key": "6_CR7_6", "doi-asserted-by": "publisher", "first-page": "1359", "DOI": "10.1016/j.juro.2007.05.136", "volume": "178", "author": "HC Kuo", "year": "2007", "unstructured": "Kuo HC (2007) Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity. J Urol 178:1359\u20131363", "journal-title": "J Urol"}, {"key": "6_CR8_6", "doi-asserted-by": "publisher", "first-page": "1767", "DOI": "10.1016/j.juro.2006.03.119", "volume": "176", "author": "I Mokhless", "year": "2006", "unstructured": "Mokhless I, Gaafar S, Fouda K, Shafik M, Assem A (2006) Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder. J Urol 176:1767\u20131770; discussion 1770", "journal-title": "J Urol"}, {"key": "6_CR9_6", "doi-asserted-by": "publisher", "first-page": "2593", "DOI": "10.1016/j.juro.2007.08.032", "volume": "178", "author": "KF Neel", "year": "2007", "unstructured": "Neel KF, Soliman S, Salem M, Seida M, Al-Hazmi H, Khatab A (2007) Botulinum-A toxin: solo treatment for neuropathic noncompliant bladder. J Urol 178:2593\u20132597; discussion 2597\u20132598", "journal-title": "J Urol"}, {"key": "6_CR10_6", "doi-asserted-by": "publisher", "first-page": "332", "DOI": "10.1016/S0022-5347(06)00298-9", "volume": "176", "author": "ZI Radojicic", "year": "2006", "unstructured": "Radojicic ZI, Perovic SV, Milic NM (2006) Is it reasonable to treat refractory voiding dysfunction in children with botulinum-A toxin? J Urol 176:332\u2013336; discussion 336", "journal-title": "J Urol"}, {"key": "6_CR11_6", "doi-asserted-by": "publisher", "first-page": "845", "DOI": "10.1097/01.ju.0000108892.35041.2d", "volume": "171", "author": "M Riccabona", "year": "2004", "unstructured": "Riccabona M, Koen M, Schindler M et al (2004) Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 171:845\u2013848", "journal-title": "J Urol"}, {"key": "6_CR12_6", "doi-asserted-by": "publisher", "first-page": "420", "DOI": "10.1542/peds.110.2.420-a", "volume": "110", "author": "H Schulte-Baukloh", "year": "2002", "unstructured": "Schulte-Baukloh H, Knispel HH, Michael T (2002a) Botulinum-A toxin in the treatment of neurogenic bladder in children. Pediatrics 110:420\u2013421", "journal-title": "Pediatrics"}, {"key": "6_CR13_6", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1016/S0090-4295(01)01641-7", "volume": "59", "author": "H Schulte-Baukloh", "year": "2002", "unstructured": "Schulte-Baukloh H, Michael T et al (2002b) Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results. Urology 59:325\u2013327; discussion 327\u2013328", "journal-title": "Urology"}, {"key": "6_CR14_6", "doi-asserted-by": "publisher", "first-page": "139", "DOI": "10.1016/S0302-2838(03)00136-2", "volume": "44", "author": "H Schulte-Baukloh", "year": "2003", "unstructured": "Schulte-Baukloh H, Michael T, Sturzebecher B, Knispel HH (2003) Botulinum-a toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder. Eur Urol 44:139\u2013143", "journal-title": "Eur Urol"}, {"key": "6_CR15_6", "doi-asserted-by": "publisher", "first-page": "865", "DOI": "10.1016/j.urology.2005.05.054", "volume": "66", "author": "H Schulte-Baukloh", "year": "2005", "unstructured": "Schulte-Baukloh H, Knispel HH, Stolze T, Weiss C, Michael T, Miller K (2005) Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity. Urology 66:865\u2013870", "journal-title": "Urology"}, {"key": "6_CR16_6", "doi-asserted-by": "publisher", "first-page": "264", "DOI": "10.1097/01.mou.0000172401.92761.86", "volume": "15", "author": "B Schurch", "year": "2005", "unstructured": "Schurch B, Corcos J (2005) Botulinum toxin injections for paediatric incontinence. Curr Opin Urol 15:264\u2013267", "journal-title": "Curr Opin Urol"}, {"key": "6_CR17_6", "doi-asserted-by": "publisher", "first-page": "2128", "DOI": "10.1097/01.ju.0000127725.48479.89", "volume": "171", "author": "CP Smith", "year": "2004", "unstructured": "Smith CP, Chancellor MB (2004) Emerging role of botulinum toxin in the management of voiding dysfunction. J Urol 171:2128\u20132137", "journal-title": "J Urol"}, {"key": "6_CR18_6", "doi-asserted-by": "publisher", "first-page": "880", "DOI": "10.1089/end.2005.19.880", "volume": "19", "author": "CP Smith", "year": "2005", "unstructured": "Smith CP, Chancellor MB (2005) Simplified bladder botulinum-toxin delivery technique using flexible cystoscope and 10 sites of injection. J Endourol 19:880\u2013882", "journal-title": "J Endourol"}, {"key": "6_CR19_6", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1016/j.urology.2004.08.016", "volume": "65", "author": "CP Smith", "year": "2005", "unstructured": "Smith CP, Nishiguchi J et al (2005) Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 65:37\u201341", "journal-title": "Urology"}, {"issue": "suppl", "key": "6_CR20_6", "first-page": "69", "volume": "93", "author": "P Verleyen", "year": "2004", "unstructured": "Verleyen P, Hoebeke P, Raes P et al (2004) The use of botulinum toxin A in children with a non-neurogenic overactive bladder: a pilot study. BJU Int 93(suppl):69\u201372", "journal-title": "BJU Int"}], "container-title": ["Botulinum Toxin in Urology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-642-03580-7_6", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 29]], "date-time": "2019-03-29T09:49:09Z", "timestamp": 1553852949000}, "score": 28.463099, "issued": {"date-parts": [[2011]]}, "ISBN": ["9783642035791", "9783642035807"], "references-count": 20, "URL": "http://dx.doi.org/10.1007/978-3-642-03580-7_6", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:43:39Z", "timestamp": 1574246619741}, "reference-count": 29, "publisher": "Wiley", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 3205, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1111/j.1742-1241.2006.01180.x", "type": "journal-article", "created": {"date-parts": [[2006, 11, 22]], "date-time": "2006-11-22T11:04:39Z", "timestamp": 1164193479000}, "page": "33-37", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Botulinum-A toxin: an exciting new treatment option for prostatic disease"], "prefix": "10.1111", "volume": "60", "author": [{"given": "C. A.", "family": "THOMAS", "sequence": "first", "affiliation": []}, {"given": "F.", "family": "GUERCINI", "sequence": "additional", "affiliation": []}, {"given": "Y-C", "family": "CHUANG", "sequence": "additional", "affiliation": []}, {"given": "M. B.", "family": "CHANCELLOR", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2006, 11, 22]]}, "reference": [{"key": "10.1111/j.1742-1241.2006.01180.x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1001/archinte.1995.00430050053006", "article-title": "New diagnostic and treatment guidelines for benign prostatic hyperplasia. Potential impact in the United States", "volume": "155", "author": "Jacobsen", "year": "1995", "journal-title": "Arch Intern Med"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB2|cit2", "author": "American Cancer Society Inc", "year": "accessed October 2006", "volume-title": "Cancer Facts and Figures"}, {"issue": "Suppl. 4", "key": "10.1111/j.1742-1241.2006.01180.x-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "S3", "DOI": "10.1111/j.1468-1331.1999.tb00032.x", "article-title": "Preclinical update on Botox (botulinum toxin type A) purified neurotoxin complex relative to other botulinum neurotoxin preparations", "volume": "6", "author": "Aoki", "year": "1999", "journal-title": "Eur J Neurol"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "2128", "DOI": "10.1097/01.ju.0000127725.48479.89", "article-title": "Emerging role of botulinum toxin in the treatment of voiding dysfunction", "volume": "171", "author": "Smith", "year": "2004", "journal-title": "J Urol"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "1896", "DOI": "10.1097/01.ju.0000049202.56189.54", "article-title": "Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract", "volume": "169", "author": "Smith", "year": "2003", "journal-title": "J Urol"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "44", "DOI": "10.1002/(SICI)1097-0045(19980915)37:1<44::AID-PROS7>3.0.CO;2-8", "article-title": "Botox induced prostatic involution", "volume": "37", "author": "Doggweiler", "year": "1998", "journal-title": "Prostate"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1046/j.1365-2680.2000.00195.x", "article-title": "The autonomic and sensory innervation of the smooth muscle of the prostate gland: a review of pharmacological and histological studies", "volume": "20", "author": "Pennefather", "year": "2000", "journal-title": "J Auton Pharmacol"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1016/S0163-7258(02)00174-2", "article-title": "Cholinergic innervation and function in the prostate gland", "volume": "94", "author": "Ventura", "year": "2002", "journal-title": "Pharmacol Ther"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB9|cit9", "first-page": "461", "article-title": "Clinical and experimental studies of benign prostatic hyperplasia", "volume": "17", "author": "Coffey", "year": "1990", "journal-title": "Urol Clin North Am"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "376", "DOI": "10.1016/S0022-5347(18)35521-6", "article-title": "Intraprostatic botulin toxin injection in patients with severe benign prostatic hyperplasia a multicenter feasibility study", "volume": "173", "author": "Guercini", "year": "2005", "journal-title": "J Urol"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1016/S0090-4295(03)00477-1", "article-title": "Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study", "volume": "62", "author": "Maria", "year": "2003", "journal-title": "Urology"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "775", "DOI": "10.1016/j.urology.2005.04.029", "article-title": "Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates", "volume": "66", "author": "Chuang", "year": "2005", "journal-title": "Urology"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "906", "DOI": "10.1016/S0022-5347(05)64541-7", "article-title": "Hereditary prostate cancer: clinical aspects", "volume": "168", "author": "Bratt", "year": "2002", "journal-title": "J Urol"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "2313", "DOI": "10.1093/hmg/10.20.2313", "article-title": "Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease", "volume": "10", "author": "Nwosu", "year": "2001", "journal-title": "Hum Mol Genet"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "2029", "DOI": "10.1210/endo.143.6.8890", "article-title": "Prostate cancer susceptibility genes", "volume": "143", "author": "Simard", "year": "2002", "journal-title": "Endocrinology"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "1276", "DOI": "10.1158/1078-0432.CCR-05-1222", "article-title": "Botulinum toxin potentiates cancer radiotherapy and chemotherapy", "volume": "12", "author": "Ansiaux", "year": "2006", "journal-title": "Clin Cancer Res"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "557", "DOI": "10.1056/NEJM199608223350809", "article-title": "Treatment of benign prostatic hyperplasia", "volume": "335", "author": "Walsh", "year": "1996", "journal-title": "N Engl J Med"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB18|cit18", "author": "Chuang", "year": "2006", "article-title": "Novel action of botulinum toxin on the stromal and epithelial components of prostate gland", "journal-title": "J Urol"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "162", "DOI": "10.1016/j.eururo.2005.01.009", "article-title": "The distribution of sensory fibers immunoreactive for the TRPV1 (capsaicin) receptor in the human prostate", "volume": "48", "author": "Dinis", "year": "2005", "journal-title": "Eur Urol"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1097/01.ju.0000121690.37499.1c", "article-title": "Prostatic tissue ablation by injection: a literature review", "volume": "172", "author": "Plante", "year": "2004", "journal-title": "J Urol"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "S6", "DOI": "10.1097/01.ju.0000142058.99614.ff", "article-title": "The role of inflammation in the pathogenesis of prostate cancer", "volume": "172", "author": "Nelson", "year": "2004", "journal-title": "J Urol"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB22|cit22", "first-page": "310", "article-title": "Seminal fluid findings in men with nonbacterial prostatitis and prostatodynia", "volume": "17", "author": "Krieger", "year": "1996", "journal-title": "J Androl"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "839", "DOI": "10.1097/01.ju.0000136002.76898.04", "article-title": "Mechanisms in prostatitis/chronic pelvic pain syndrome", "volume": "172", "author": "Pontari", "year": "2004", "journal-title": "J Urol"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1046/j.1365-2680.2000.00195.x", "article-title": "The autonomic and sensory innervation of the smooth muscle of the prostate gland: a review of pharmacological and histological studies", "volume": "20", "author": "Pennefather", "year": "2000", "journal-title": "J Auton Pharmacol"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "1529", "DOI": "10.1097/01.ju.0000137844.77524.97", "article-title": "Intravesical botulinum toxin A administration produces analgesia against acetic acid induced bladder pain responses in rats", "volume": "172", "author": "Chuang", "year": "2004", "journal-title": "J Urol"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "871", "DOI": "10.1016/j.urology.2004.06.073", "article-title": "Botulinum toxin-A has antinociceptive effects in treating interstitial cystitis", "volume": "64", "author": "Smith", "year": "2005", "journal-title": "Urology"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB27|cit27", "author": "Chuang", "first-page": "??", "year": "2006", "article-title": "Intraprostatic capsaicin injection as a novel model for non-bacterial prostatitis", "journal-title": "AUA Proceedings Abstract"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "12", "DOI": "10.1186/1471-2490-6-12", "article-title": "Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs", "volume": "6", "author": "Chuang", "year": "2006", "journal-title": "BMC Urol"}, {"key": "10.1111/j.1742-1241.2006.01180.x-BIB29|cit29", "author": "Chuang", "year": "2006", "article-title": "The potential and promise of using botulinum toxin in the prostate gland", "journal-title": "BJU Int", "DOI": "10.1111/j.1464-410X.2006.06184.x", "doi-asserted-by": "crossref"}], "container-title": ["International Journal of Clinical Practice"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1742-1241.2006.01180.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 15]], "date-time": "2019-01-15T04:18:18Z", "timestamp": 1547525898000}, "score": 27.971022, "subtitle": ["BOTULINUM TOXIN IN THE PROSTATE"], "issued": {"date-parts": [[2006, 11, 22]]}, "references-count": 29, "URL": "http://dx.doi.org/10.1111/j.1742-1241.2006.01180.x", "relation": {"cites": []}, "ISSN": ["1368-5031"], "issn-type": [{"value": "1368-5031", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T09:33:04Z", "timestamp": 1574155984221}, "publisher-location": "Basel", "reference-count": 0, "publisher": "KARGER", "isbn-type": [{"value": "3805573065", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2002]]}, "DOI": "10.1159/000060682", "type": "book-chapter", "created": {"date-parts": [[2004, 12, 13]], "date-time": "2004-12-13T09:51:27Z", "timestamp": 1102931487000}, "page": "101-106", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Botulinum Toxin in Warfare"], "prefix": "10.1159", "author": [{"given": "R.", "family": "B\ufffdni", "sequence": "first", "affiliation": []}], "member": "127", "container-title": ["Hyperhidrosis and Botulinum Toxin in Dermatology", "Current Problems in Dermatology"], "link": [{"URL": "http://www.karger.com/Article/Pdf/60682", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 10, 25]], "date-time": "2017-10-25T19:45:21Z", "timestamp": 1508960721000}, "score": 27.389814, "issued": {"date-parts": [[2002]]}, "ISBN": ["3805573065"], "references-count": 0, "URL": "http://dx.doi.org/10.1159/000060682"}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T09:24:51Z", "timestamp": 1574155491932}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2003, 2]]}, "DOI": "10.1067/maj.2003.5", "type": "journal-article", "created": {"date-parts": [[2003, 3, 12]], "date-time": "2003-03-12T21:41:09Z", "timestamp": 1047505269000}, "page": "67-69", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Botulinum toxin A for managing focal hyperhidrosis"], "prefix": "10.1093", "volume": "23", "author": [{"given": "Robert F.", "family": "Centeno", "sequence": "first", "affiliation": []}, {"given": "Craig B.", "family": "Boswell", "sequence": "additional", "affiliation": []}, {"given": "Alan", "family": "Matarasso", "sequence": "additional", "affiliation": []}], "member": "286", "container-title": ["Aesthetic Surgery Journal"], "deposited": {"date-parts": [[2015, 1, 7]], "date-time": "2015-01-07T13:47:14Z", "timestamp": 1420638434000}, "score": 27.213491, "issued": {"date-parts": [[2003, 2]]}, "references-count": 0, "journal-issue": {"issue": "1"}, "alternative-id": ["10.1067/maj.2003.5"], "URL": "http://dx.doi.org/10.1067/maj.2003.5", "ISSN": ["1090-820X"], "issn-type": [{"value": "1090-820X", "type": "print"}], "article-number": "amaj035"}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T05:52:56Z", "timestamp": 1574401976683}, "publisher-location": "Cambridge", "reference-count": 0, "publisher": "Cambridge University Press", "isbn-type": [{"value": "9780521694421", "type": "print"}, {"value": "9780511575761", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1017/cbo9780511575761.012", "type": "book-chapter", "created": {"date-parts": [[2009, 12, 24]], "date-time": "2009-12-24T12:47:19Z", "timestamp": 1261658839000}, "page": "77-84", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Botulinum toxin applications in ophthalmology"], "prefix": "10.1017", "author": [{"given": "Peter", "family": "Roggenkaemper", "sequence": "first", "affiliation": []}, {"given": "Alan B.", "family": "Scott", "sequence": "additional", "affiliation": []}], "member": "56", "container-title": ["Manual of Botulinum Toxin Therapy"], "deposited": {"date-parts": [[2018, 4, 13]], "date-time": "2018-04-13T09:11:44Z", "timestamp": 1523610704000}, "score": 27.103376, "editor": [{"given": "Daniel", "family": "Truong", "sequence": "additional", "affiliation": []}, {"given": "Dirk", "family": "Dressler", "sequence": "additional", "affiliation": []}, {"given": "Mark", "family": "Hallett", "sequence": "additional", "affiliation": []}], "issued": {"date-parts": [[null]]}, "ISBN": ["9780511575761", "9780521694421"], "references-count": 0, "URL": "http://dx.doi.org/10.1017/cbo9780511575761.012"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T14:41:29Z", "timestamp": 1574520089745}, "reference-count": 38, "publisher": "Elsevier", "isbn-type": [{"value": "9781416049289", "type": "print"}], "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 1, 1]], "date-time": "2009-01-01T00:00:00Z", "timestamp": 1230768000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2009]]}, "DOI": "10.1016/b978-1-4160-4928-9.00022-6", "type": "book-chapter", "created": {"date-parts": [[2011, 6, 21]], "date-time": "2011-06-21T21:26:37Z", "timestamp": 1308691597000}, "page": "273-282.e1", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Application of Botulinum Toxin in the Prostate"], "prefix": "10.1016", "author": [{"given": "Yao-Chi", "family": "Chuang", "sequence": "first", "affiliation": []}, {"given": "Michael B.", "family": "Chancellor", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Botulinum Toxin"], "link": [{"URL": "https://api.elsevier.com/content/article/PII:B9781416049289000226?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:B9781416049289000226?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 2]], "date-time": "2019-04-02T06:51:27Z", "timestamp": 1554187887000}, "score": 26.736238, "issued": {"date-parts": [[2009]]}, "ISBN": ["9781416049289"], "references-count": 38, "URL": "http://dx.doi.org/10.1016/b978-1-4160-4928-9.00022-6"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T14:49:58Z", "timestamp": 1574520598378}, "publisher-location": "Berlin, Heidelberg", "reference-count": 11, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642035791", "type": "print"}, {"value": "9783642035807", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011]]}, "DOI": "10.1007/978-3-642-03580-7_10", "type": "book-chapter", "created": {"date-parts": [[2011, 6, 24]], "date-time": "2011-06-24T08:58:21Z", "timestamp": 1308905901000}, "page": "169-175", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Health Economics of Botulinum Toxin Application"], "prefix": "10.1007", "author": [{"given": "Michael B.", "family": "Chancellor", "sequence": "first", "affiliation": []}, {"given": "Christopher P.", "family": "Smith", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 5, 2]]}, "reference": [{"key": "10_CR1_10", "doi-asserted-by": "publisher", "first-page": "835", "DOI": "10.1016/S0022-5347(05)00326-5", "volume": "175", "author": "M Brazzelli", "year": "2006", "unstructured": "Brazzelli M, Murray A, Fraser C (2006) Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review. J Urol 175:835\u2013841", "journal-title": "J Urol"}, {"key": "10_CR2_10", "unstructured": "Campbell J, Velard M, Denys P, Chartier-Kastler E, Kowalski J, Sullivan S (2010) Cost-effectiveness and financial impact of onabotulinumtoxinA treatment for urinary incontinence due to neurogenic detrusor overactivity in spinal cord injury patients within the French healthcare system. ICS. Abstract 358"}, {"key": "10_CR3_10", "doi-asserted-by": "publisher", "first-page": "511", "DOI": "10.1046/j.1464-4096.2001.001206", "volume": "88", "author": "TJ Greenwell", "year": "2001", "unstructured": "Greenwell TJ, Venn SN, Mundy AR (2001) Augmentation cystoplasty. BJU Int 88:511\u2013525", "journal-title": "BJU Int"}, {"key": "10_CR4_10", "doi-asserted-by": "publisher", "first-page": "931", "DOI": "10.1111/j.1368-5031.2005.00617.x", "volume": "59", "author": "H Haab", "year": "2005", "unstructured": "Haab H, Castro-Diaz D (2005) Persistence with antimuscarinic therapy in patients with overactive bladder. Int J Clin Pract 59:931\u2013937", "journal-title": "Int J Clin Pract"}, {"key": "10_CR5_10", "doi-asserted-by": "publisher", "first-page": "1123", "DOI": "10.1016/S0090-4295(03)00009-8", "volume": "61", "author": "T Hu", "year": "2003", "unstructured": "Hu T, Wagner TH, Benkover JD (2003) Estimated costs of overactive bladder in the United States. Urology 61:1123\u20131128, 2003", "journal-title": "Urology"}, {"key": "10_CR6_10", "doi-asserted-by": "publisher", "first-page": "519", "DOI": "10.1016/j.eururo.2005.11.006", "volume": "49", "author": "V Kalsi", "year": "2006", "unstructured": "Kalsi V, Popat RB, Apostolidis A, Kavia R, Odeyemi IA, Dakin HA, Warner J, Elneil S, Fowler CJ, Dasgupta P (2006) Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre. Eur Urol 49:519\u2013527", "journal-title": "Eur Urol"}, {"key": "10_CR7_10", "unstructured": "Padmanabhan P, Scarpero H, Milam D, Dmochowski R, Penson D. 5 year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity. ICS. 2010. Abstract 530", "DOI": "10.1016/j.juro.2010.02.408", "doi-asserted-by": "crossref"}, {"key": "10_CR8_10", "unstructured": "Robinson R, Moore K, Haq A (2010a) Dysport\u00ae versus Botox\u00ae in the treatment of idiopathic detrusor overactivity. A financial and outcome evaluation. ICS. Abstract 354"}, {"key": "10_CR9_10", "unstructured": "Robinson D, Jacklin P, Cardozo L (2010b) What\u2019s needling us about the management of refractory overactive bladder? An economic analysis of the use of percutaneous tibial nerve stimulation and botulinum toxin. ICS. Abstract 180"}, {"key": "10_CR10_10", "doi-asserted-by": "publisher", "first-page": "835", "DOI": "10.1016/j.urology.2010.01.080", "volume": "76", "author": "JH Watanabe", "year": "2010", "unstructured": "Watanabe JH, Campbell JD, Ravelo A, Chancellor MB, Kowalski J, Sullivan S (2010) Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder. Urology 76:835\u2013840", "journal-title": "Urology"}, {"key": "10_CR11_10", "doi-asserted-by": "publisher", "first-page": "2181", "DOI": "10.1016/j.juro.2009.01.037", "volume": "181", "author": "JM Wu", "year": "2009", "unstructured": "Wu JM, Siddiqui NY, Amundsen CL, Myers ER, Havrilesky LJ, Visco AG (2009) Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence. J Urol 181:2181\u20132186", "journal-title": "J Urol"}], "container-title": ["Botulinum Toxin in Urology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-642-03580-7_10", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 12]], "date-time": "2019-06-12T05:46:58Z", "timestamp": 1560318418000}, "score": 26.736238, "issued": {"date-parts": [[2011]]}, "ISBN": ["9783642035791", "9783642035807"], "references-count": 11, "URL": "http://dx.doi.org/10.1007/978-3-642-03580-7_10", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T14:49:50Z", "timestamp": 1574520590726}, "publisher-location": "Berlin, Heidelberg", "reference-count": 42, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642035791", "type": "print"}, {"value": "9783642035807", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011]]}, "DOI": "10.1007/978-3-642-03580-7_3", "type": "book-chapter", "created": {"date-parts": [[2011, 6, 24]], "date-time": "2011-06-24T08:58:21Z", "timestamp": 1308905901000}, "page": "29-59", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Botulinum Toxin for Neurogenic Detrusor Overactivity"], "prefix": "10.1007", "author": [{"given": "Michael B.", "family": "Chancellor", "sequence": "first", "affiliation": []}, {"given": "Christopher P.", "family": "Smith", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 5, 2]]}, "reference": [{"issue": "2", "key": "3_CR1_3", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1007/s11255-009-9600-7", "volume": "42", "author": "MB Chancellor", "year": "2010", "unstructured": "Chancellor MB (2010) Ten years single surgeon experience with botulinum toxin in the urinary tract; clinical observations and research discovery. Int Urol Nephrol 42(2):383\u2013391", "journal-title": "Int Urol Nephrol"}, {"key": "3_CR41_3", "unstructured": "Chancellor MB, Patel V, Leng W, Shenot P, Lam W, Chapple C (2011) OnabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: effects on health related quality of life. 2011 American Urological Association Annual Meeting. May 2011, Abstract1518."}, {"issue": "8", "key": "3_CR2_3", "doi-asserted-by": "publisher", "first-page": "490", "DOI": "10.1038/sj.sc.3101033", "volume": "38", "author": "EJ Chartier-Kastler", "year": "2000", "unstructured": "Chartier-Kastler EJ, Mongiat-Artus P, Bitker MO, Chancellor MB, Richard F, Denys P (2000) Long-term results of augmentation cystoplasty in spinal cord injury patients. Spinal Cord 38(8):490\u2013494", "journal-title": "Spinal Cord"}, {"issue": "5", "key": "3_CR3_3", "doi-asserted-by": "publisher", "first-page": "884", "DOI": "10.1016/j.eururo.2009.12.022", "volume": "57", "author": "A Coelho", "year": "2009", "unstructured": "Coelho A, Dinis P, Pinto R, Gorgal T, Silva C, Silva A, Silva J, Cruz CD, Cruz F, Avelino A (2009) Distribution of the high-affinity binding site and intracellular target of botulinum toxin type A in the human bladder. Eur Urol 57(5):884\u2013890", "journal-title": "Eur Urol"}, {"issue": "5", "key": "3_CR4_3", "doi-asserted-by": "publisher", "first-page": "1058", "DOI": "10.1016/j.eururo.2006.01.025", "volume": "50", "author": "E Comperat", "year": "2006", "unstructured": "Comperat E, Reitz A, Delcourt A, Capron F, Denys P, Chartier-Kastler E (2006) Histologic features in the urinary bladder wall affected from neurogenic overactivity \u2013 a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A. Eur Urol 50(5):1058\u20131064", "journal-title": "Eur Urol"}, {"issue": "6", "key": "3_CR5_3", "doi-asserted-by": "publisher", "first-page": "3200", "DOI": "10.1073/pnas.96.6.3200", "volume": "96", "author": "A Paiva de", "year": "1999", "unstructured": "de Paiva A, Meunier FA, Molgo J, Aoki KR, Dolly JO (1999) Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 96(6):3200\u20133205", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "5", "key": "3_CR6_3", "doi-asserted-by": "publisher", "first-page": "1013", "DOI": "10.1016/j.eururo.2007.09.034", "volume": "53", "author": "G Popolo Del", "year": "2008", "unstructured": "Del Popolo G, Filocamo MT, Li Marzi V, Macchiarella A, Cecconi F, Lombardi G, Nicita G (2008) Neurogenic detrusor overactivity treated with English botulinum toxin A: 8-year experience of one single centre. Eur Urol 53(5):1013\u20131019", "journal-title": "Eur Urol"}, {"issue": "4", "key": "3_CR7_3", "doi-asserted-by": "publisher", "first-page": "335", "DOI": "10.1080/00365590601068835", "volume": "41", "author": "I Ehren", "year": "2007", "unstructured": "Ehren I, Volz D, Farrelly E, Berglund L, Brundin L, Hultling C, Lafolie P (2007) Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: a randomised, placebo-controlled, double-blind study. Scand J Urol Nephrol 41(4):335\u2013340", "journal-title": "Scand J Urol Nephrol"}, {"issue": "3", "key": "3_CR8_3", "doi-asserted-by": "publisher", "first-page": "135", "DOI": "10.1016/S0304-3940(98)00775-7", "volume": "256", "author": "R Eleopra", "year": "1998", "unstructured": "Eleopra R, Tugnoli V, Rossetto O, De Grandis D, Montecucco C (1998) Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans. Neurosci Lett 256(3):135\u2013138", "journal-title": "Neurosci Lett"}, {"issue": "2", "key": "3_CR9_3", "doi-asserted-by": "publisher", "first-page": "1363", "DOI": "10.1074/jbc.M209821200", "volume": "278", "author": "PG Foran", "year": "2003", "unstructured": "Foran PG, Mohammed N, Lisk GO, Nagwaney S, Lawrence GW, Johnson E, Smith L, Aoki KR, Dolly JO (2003) Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. J Biol Chem 278(2):1363\u20131371", "journal-title": "J Biol Chem"}, {"issue": "1", "key": "3_CR10_3", "doi-asserted-by": "publisher", "first-page": "103", "DOI": "10.1002/nau.20371", "volume": "26", "author": "CJ Fowler", "year": "2007", "unstructured": "Fowler CJ (2007) Update on the neurology of Parkinson\u2019s disease. Neurourol Urodyn 26(1):103\u2013109", "journal-title": "Neurourol Urodyn"}, {"issue": "3", "key": "3_CR11_3", "doi-asserted-by": "publisher", "first-page": "613", "DOI": "10.1016/j.eururo.2007.08.039", "volume": "53", "author": "X Game", "year": "2008", "unstructured": "Game X, Castel-Lacanal E, Bentaleb Y, Thiry-Escudie I, De Boissezon X, Malavaud B, Marque P, Rischmann P (2008) Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol 53(3):613\u2013618", "journal-title": "Eur Urol"}, {"issue": "5", "key": "3_CR12_3", "doi-asserted-by": "publisher", "first-page": "1873", "DOI": "10.1097/01.ju.0000177477.83991.88", "volume": "174", "author": "M Ghei", "year": "2005", "unstructured": "Ghei M, Maraj BH, Miller R, Nathan S, O\u2019Sullivan C, Fowler CJ, Shah PJ, Malone-Lee J (2005) Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial. J Urol 174(5):1873\u20131877; discussion 1877", "journal-title": "J Urol"}, {"issue": "1", "key": "3_CR13_3", "doi-asserted-by": "publisher", "first-page": "240", "DOI": "10.1097/01.ju.0000132152.53532.5d", "volume": "172", "author": "A Giannantoni", "year": "2004", "unstructured": "Giannantoni A, Di Stasi SM, Stephen RL, Bini V, Costantini E, Porena M (2004) Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. J Urol 172(1):240\u2013243", "journal-title": "J Urol"}, {"issue": "4", "key": "3_CR14_3", "doi-asserted-by": "publisher", "first-page": "1453", "DOI": "10.1016/j.juro.2009.06.023", "volume": "182", "author": "A Giannantoni", "year": "2009", "unstructured": "Giannantoni A, Rossi A, Mearini E, Del Zingaro M, Porena M, Berardelli A (2009) Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson\u2019s disease and multiple system atrophy. J Urol 182(4):1453\u20131457", "journal-title": "J Urol"}, {"key": "3_CR42_3", "unstructured": "Ginsberg D, Gousse A, Keppenne V, Sievert KD, Thompson C, Lam W, Jenkins B, Haag Molkenteller C (2011) Phase 3 efficacy and safety study of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity. 2011 American Urological Association Annual Meeting. May 2011, Abstract 1515."}, {"issue": "5", "key": "3_CR15_3", "doi-asserted-by": "publisher", "first-page": "653", "DOI": "10.1016/j.eururo.2004.11.009", "volume": "47", "author": "J Grosse", "year": "2005", "unstructured": "Grosse J, Kramer G, Stohrer M (2005) Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 47(5):653\u2013659", "journal-title": "Eur Urol"}, {"issue": "6", "key": "3_CR16_3", "doi-asserted-by": "publisher", "first-page": "784", "DOI": "10.1016/j.eururo.2004.07.011", "volume": "46", "author": "A Haferkamp", "year": "2004", "unstructured": "Haferkamp A, Schurch B, Reitz A, Krengel U, Grosse J, Kramer G, Schumacher S, Bastian PJ, Buttner R, Muller SC, Stohrer M (2004) Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder. Eur Urol 46(6):784\u2013791", "journal-title": "Eur Urol"}, {"issue": "7", "key": "3_CR17_3", "doi-asserted-by": "publisher", "first-page": "1186", "DOI": "10.1212/01.WNL.0000055087.96356.BB", "volume": "60", "author": "J Jankovic", "year": "2003", "unstructured": "Jankovic J, Vuong KD, Ahsan J (2003) Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology 60(7):1186\u20131188", "journal-title": "Neurology"}, {"issue": "1", "key": "3_CR18_3", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1016/j.eururo.2007.12.029", "volume": "54", "author": "V Kalsi", "year": "2008", "unstructured": "Kalsi V, Apostolidis A, Gonzales G, Elneil S, Dasgupta P, Fowler CJ (2008) Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity. Eur Urol 54(1):181\u2013187", "journal-title": "Eur Urol"}, {"issue": "1", "key": "3_CR19_3", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1016/S0022-5347(17)37727-3", "volume": "146", "author": "SA Kaplan", "year": "1991", "unstructured": "Kaplan SA, Chancellor MB, Blaivas JG (1991) Bladder and sphincter behavior in patients with spinal cord lesions. J Urol 146(1):113\u2013117", "journal-title": "J Urol"}, {"issue": "2", "key": "3_CR20_3", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1016/j.eururo.2007.10.013", "volume": "53", "author": "G Karsenty", "year": "2008", "unstructured": "Karsenty G, Denys P, Amarenco G, De Seze M, Game X, Haab F, Kerdraon J, Perrouin-Verbe B, Ruffion A, Saussine C, Soler JM, Schurch B, Chartier-Kastler E (2008) Botulinum toxin A (botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Eur Urol 53(2):275\u2013287", "journal-title": "Eur Urol"}, {"issue": "3", "key": "3_CR21_3", "doi-asserted-by": "publisher", "first-page": "1011", "DOI": "10.1016/j.juro.2006.10.047", "volume": "177", "author": "G Karsenty", "year": "2007", "unstructured": "Karsenty G, Elzayat E, Delapparent T, St-Denis B, Lemieux MC, Corcos J (2007) Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux. J Urol 177(3):1011\u20131014", "journal-title": "J Urol"}, {"issue": "16", "key": "3_CR22_3", "doi-asserted-by": "publisher", "first-page": "13476", "DOI": "10.1074/jbc.M010992200", "volume": "276", "author": "JE Keller", "year": "2001", "unstructured": "Keller JE, Neale EA (2001) The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A. J Biol Chem 276(16):13476\u201313482", "journal-title": "J Biol Chem"}, {"issue": "1", "key": "3_CR23_3", "doi-asserted-by": "publisher", "first-page": "137", "DOI": "10.1016/S0014-5793(99)00948-5", "volume": "456", "author": "JE Keller", "year": "1999", "unstructured": "Keller JE, Neale EA, Oyler G, Adler M (1999) Persistence of botulinum neurotoxin action in cultured spinal cord cells. FEBS Lett 456(1):137\u2013142", "journal-title": "FEBS Lett"}, {"issue": "11", "key": "3_CR24_3", "doi-asserted-by": "publisher", "first-page": "2114", "DOI": "10.1016/j.apmr.2005.06.008", "volume": "86", "author": "J Klaphajone", "year": "2005", "unstructured": "Klaphajone J, Kitisomprayoonkul W, Sriplakit S (2005) Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions. Arch Phys Med Rehabil 86(11):2114\u20132118", "journal-title": "Arch Phys Med Rehabil"}, {"issue": "4 Pt 1", "key": "3_CR25_3", "doi-asserted-by": "publisher", "first-page": "1359", "DOI": "10.1016/j.juro.2007.05.136", "volume": "178", "author": "HC Kuo", "year": "2007", "unstructured": "Kuo HC (2007) Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity. J Urol 178(4 Pt 1):1359\u20131363", "journal-title": "J Urol"}, {"issue": "15", "key": "3_CR26_3", "doi-asserted-by": "publisher", "first-page": "1367", "DOI": "10.1212/WNL.0b013e3181a53375", "volume": "72", "author": "A Mauskop", "year": "2009", "unstructured": "Mauskop A, Mathew N (2009) Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology 72(15):1367; author reply 1367\u20131368", "journal-title": "Neurology"}, {"issue": "3", "key": "3_CR27_3", "doi-asserted-by": "publisher", "first-page": "397", "DOI": "10.1007/s00345-008-0362-0", "volume": "27", "author": "U Mehnert", "year": "2009", "unstructured": "Mehnert U, Boy S, Schmid M, Reitz A, von Hessling A, Hodler J, Schurch B (2009) A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging. World J Urol 27(3):397\u2013403", "journal-title": "World J Urol"}, {"issue": "3", "key": "3_CR28_3", "doi-asserted-by": "publisher", "first-page": "360", "DOI": "10.1016/j.eururo.2010.02.031", "volume": "58", "author": "R Pinto", "year": "2010", "unstructured": "Pinto R, Lopes T, Frias B, Silva A, Silva JA, Silva CM, Cruz C, Cruz F, Dinis P (2010) Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol 58(3):360\u2013365", "journal-title": "Eur Urol"}, {"issue": "1", "key": "3_CR29_3", "doi-asserted-by": "publisher", "first-page": "177", "DOI": "10.1016/S0022-5347(06)00590-8", "volume": "176", "author": "DM Schmid", "year": "2006", "unstructured": "Schmid DM, Sauermann P, Werner M, Schuessler B, Blick N, Muentener M, Strebel RT, Perucchini D, Scheiner D, Schaer G, John H, Reitz A, Hauri D, Schurch B (2006) Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176(1):177\u2013185", "journal-title": "J Urol"}, {"issue": "5", "key": "3_CR30_3", "doi-asserted-by": "publisher", "first-page": "407", "DOI": "10.1111/j.1442-2042.2008.02016.x", "volume": "15", "author": "H Schulte-Baukloh", "year": "2008", "unstructured": "Schulte-Baukloh H, Bigalke H, Miller K, Heine G, Pape D, Lehmann J, Knispel HH (2008) Botulinum neurotoxin type A in urology: antibodies as a cause of therapy failure. Int J Urol 15(5):407\u2013415; discussion 415", "journal-title": "Int J Urol"}, {"issue": "3", "key": "3_CR31_3", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1016/S0090-4295(01)01641-7", "volume": "59", "author": "H Schulte-Baukloh", "year": "2002", "unstructured": "Schulte-Baukloh H, Michael T, Schobert J, Stolze T, Knispel HH (2002) Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results. Urology 59(3):325\u2013327; discussion 327\u2013328", "journal-title": "Urology"}, {"issue": "1", "key": "3_CR32_3", "doi-asserted-by": "publisher", "first-page": "196", "DOI": "10.1097/01.ju.0000162035.73977.1c", "volume": "174", "author": "B Schurch", "year": "2005", "unstructured": "Schurch B, de Seze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, Plante P, Perrouin-Verbe B, Kumar C, Fraczek S, Brin MF (2005) Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174(1):196\u2013200", "journal-title": "J Urol"}, {"issue": "3 Pt 1", "key": "3_CR33_3", "doi-asserted-by": "crossref", "first-page": "692", "DOI": "10.1016/S0022-5347(05)67283-7", "volume": "164", "author": "B Schurch", "year": "2000", "unstructured": "Schurch B, Stohrer M, Kramer G, Schmid DM, Gaul G, Hauri D (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164(3 Pt 1):692\u2013697", "journal-title": "J Urol"}, {"issue": "1", "key": "3_CR34_3", "doi-asserted-by": "publisher", "first-page": "189", "DOI": "10.1212/WNL.49.1.189", "volume": "49", "author": "RR Sloop", "year": "1997", "unstructured": "Sloop RR, Cole BA, Escutin RO (1997) Human response to botulinum toxin injection: type B compared with type A. Neurology 49(1):189\u2013194", "journal-title": "Neurology"}, {"issue": "6 Pt 1", "key": "3_CR35_3", "doi-asserted-by": "publisher", "first-page": "2128", "DOI": "10.1097/01.ju.0000127725.48479.89", "volume": "171", "author": "CP Smith", "year": "2004", "unstructured": "Smith CP, Chancellor MB (2004) Emerging role of botulinum toxin in the management of voiding dysfunction. J Urol 171(6 Pt 1):2128\u20132137", "journal-title": "J Urol"}, {"issue": "7", "key": "3_CR36_3", "doi-asserted-by": "publisher", "first-page": "880", "DOI": "10.1089/end.2005.19.880", "volume": "19", "author": "CP Smith", "year": "2005", "unstructured": "Smith CP, Chancellor MB (2005) Simplified bladder botulinum-toxin delivery technique using flexible cystoscope and 10 sites of injection. J Endourol 19(7):880\u2013882", "journal-title": "J Endourol"}, {"issue": "1", "key": "3_CR37_3", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1016/j.urology.2004.08.016", "volume": "65", "author": "CP Smith", "year": "2005", "unstructured": "Smith CP, Nishiguchi J, O\u2019Leary M, Yoshimura N, Chancellor MB (2005) Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 65(1):37\u201341", "journal-title": "Urology"}, {"issue": "2", "key": "3_CR38_3", "doi-asserted-by": "publisher", "first-page": "116", "DOI": "10.1002/nau.20193", "volume": "25", "author": "K Winge", "year": "2006", "unstructured": "Winge K, Skau AM, Stimpel H, Nielsen KK, Werdelin L (2006) Prevalence of bladder dysfunction in Parkinsons disease. Neurourol Urodyn 25(2):116\u2013122", "journal-title": "Neurourol Urodyn"}, {"issue": "6", "key": "3_CR39_3", "doi-asserted-by": "crossref", "first-page": "783", "DOI": "10.1016/S0022-5347(17)56990-6", "volume": "121", "author": "JR Woodside", "year": "1979", "unstructured": "Woodside JR, McGuire EJ (1979) Urethral hypotonicity after suprasacral spinal cord injury. J Urol 121(6):783\u2013785", "journal-title": "J Urol"}, {"issue": "6", "key": "3_CR40_3", "doi-asserted-by": "crossref", "first-page": "1026", "DOI": "10.1016/S0022-5347(17)58286-5", "volume": "118", "author": "SV Yalla", "year": "1977", "unstructured": "Yalla SV, Blunt KJ, Fam BA, Constantinople NL, Gittes RF (1977) Detrusor-urethral sphincter dyssynergia. J Urol 118(6):1026\u20131029", "journal-title": "J Urol"}], "container-title": ["Botulinum Toxin in Urology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-642-03580-7_3", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 29]], "date-time": "2019-03-29T09:28:03Z", "timestamp": 1553851683000}, "score": 26.736238, "issued": {"date-parts": [[2011]]}, "ISBN": ["9783642035791", "9783642035807"], "references-count": 42, "URL": "http://dx.doi.org/10.1007/978-3-642-03580-7_3", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T14:49:50Z", "timestamp": 1574520590739}, "publisher-location": "Berlin, Heidelberg", "reference-count": 29, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642035791", "type": "print"}, {"value": "9783642035807", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011]]}, "DOI": "10.1007/978-3-642-03580-7_7", "type": "book-chapter", "created": {"date-parts": [[2011, 6, 24]], "date-time": "2011-06-24T08:58:21Z", "timestamp": 1308905901000}, "page": "111-130", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Botulinum Toxin Injection for Prostate Disorders"], "prefix": "10.1007", "author": [{"given": "Michael B.", "family": "Chancellor", "sequence": "first", "affiliation": []}, {"given": "Christopher P.", "family": "Smith", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 5, 2]]}, "reference": [{"issue": "6", "key": "7_CR1_7", "doi-asserted-by": "publisher", "first-page": "1245", "DOI": "10.1016/j.eururo.2008.02.037", "volume": "53", "author": "A Apostolidis", "year": "2008", "unstructured": "Apostolidis A, Jacques TS, Freeman A, Kalsi V, Popat R, Gonzales G, Datta SN, Ghazi-Noori S, Elneil S, Dasgupta P, Fowler CJ (2008) Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity. Eur Urol 53(6):1245\u20131253", "journal-title": "Eur Urol"}, {"issue": "5", "key": "7_CR2_7", "doi-asserted-by": "publisher", "first-page": "250", "DOI": "10.1038/sj.pcan.4500246", "volume": "1", "author": "EA Benaim", "year": "1998", "unstructured": "Benaim EA, Montoya JD, Saboorian MH, Litwiller S, Roehrborn CG (1998) Characterization of prostate size, PSA and endocrine profiles in patients with spinal cord injuries. Prostate Cancer Prostatic Dis 1(5):250\u2013255", "journal-title": "Prostate Cancer Prostatic Dis"}, {"issue": "1", "key": "7_CR3_7", "doi-asserted-by": "publisher", "first-page": "90", "DOI": "10.1016/j.urology.2008.08.475", "volume": "73", "author": "G Brisinda", "year": "2009", "unstructured": "Brisinda G, Cadeddu F, Vanella S, Mazzeo P, Marniga G, Maria G (2009) Relief by botulinum toxin of lower urinary tract symptoms owing to benign prostatic hyperplasia: early and long-term results. Urology 73(1):90\u201394", "journal-title": "Urology"}, {"issue": "6", "key": "7_CR4_7", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1038/ncpuro1124", "volume": "5", "author": "MB Chancellor", "year": "2008", "unstructured": "Chancellor MB, Fowler CJ, Apostolidis A, de Groat WC, Smith CP, Somogyi GT, Aoki KR (2008) Drug insight: biological effects of botulinum toxin A in the lower urinary tract. Nat Clin Pract Urol 5(6):319\u2013328", "journal-title": "Nat Clin Pract Urol"}, {"issue": "4", "key": "7_CR5_7", "doi-asserted-by": "publisher", "first-page": "775", "DOI": "10.1016/j.urology.2005.04.029", "volume": "66", "author": "YC Chuang", "year": "2005", "unstructured": "Chuang YC, Chiang PH, Huang CC, Yoshimura N, Chancellor MB (2005) Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates. Urology 66(4):775\u2013779", "journal-title": "Urology"}, {"issue": "5", "key": "7_CR6_7", "doi-asserted-by": "publisher", "first-page": "1033", "DOI": "10.1111/j.1464-410X.2006.06479.x", "volume": "98", "author": "YC Chuang", "year": "2006", "unstructured": "Chuang YC, Chiang PH, Yoshimura N, De Miguel F, Chancellor MB (2006a) Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia. BJU Int 98(5):1033\u20131037; discussion 1337", "journal-title": "BJU Int"}, {"issue": "3 Pt 1", "key": "7_CR7_7", "doi-asserted-by": "publisher", "first-page": "1158", "DOI": "10.1016/S0022-5347(05)00318-6", "volume": "175", "author": "YC Chuang", "year": "2006", "unstructured": "Chuang YC, Huang CC, Kang HY, Chiang PH, Demiguel F, Yoshimura N, Chancellor MB (2006b) Novel action of botulinum toxin on the stromal and epithelial components of the prostate gland. J Urol 175(3 Pt 1):1158\u20131163", "journal-title": "J Urol"}, {"key": "7_CR8_7", "doi-asserted-by": "publisher", "first-page": "12", "DOI": "10.1186/1471-2490-6-12", "volume": "6", "author": "YC Chuang", "year": "2006", "unstructured": "Chuang YC, Tu CH, Huang CC, Lin HJ, Chiang PH, Yoshimura N, Chancellor MB (2006c) Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs. BMC Urol 6:12. doi:\n                  doi:10.1186/1471-2490-6-12", "journal-title": "BMC Urol"}, {"issue": "2", "key": "7_CR9_7", "doi-asserted-by": "publisher", "first-page": "742", "DOI": "10.1016/j.juro.2007.07.120", "volume": "180", "author": "YC Chuang", "year": "2008", "unstructured": "Chuang YC, Yoshimura N, Huang CC, Wu M, Chiang PH, Chancellor MB (2008) Intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat. J Urol 180(2):742\u2013748", "journal-title": "J Urol"}, {"issue": "1", "key": "7_CR10_7", "doi-asserted-by": "publisher", "first-page": "44", "DOI": "10.1002/(SICI)1097-0045(19980915)37:1<44::AID-PROS7>3.0.CO;2-8", "volume": "37", "author": "R Doggweiler", "year": "1998", "unstructured": "Doggweiler R, Zermann DH, Ishigooka M, Schmidt RA (1998) Botox-induced prostatic involution. Prostate 37(1):44\u201350", "journal-title": "Prostate"}, {"issue": "6", "key": "7_CR11_7", "doi-asserted-by": "publisher", "first-page": "2341", "DOI": "10.1016/S0022-5347(06)00258-8", "volume": "175", "author": "A Giannantoni", "year": "2006", "unstructured": "Giannantoni A, Di Stasi SM, Nardicchi V, Zucchi A, Macchioni L, Bini V, Goracci G, Porena M (2006) Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. J Urol 175(6):2341\u20132344", "journal-title": "J Urol"}, {"issue": "2 Pt 2", "key": "7_CR12_7", "doi-asserted-by": "publisher", "first-page": "1102", "DOI": "10.1016/S0022-5347(02)80349-4", "volume": "167", "author": "GJ Gormley", "year": "2002", "unstructured": "Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS, Vaughan ED, Pappas F, Taylor A, Binkowitz B, Ng J (2002) The effect of finasteride in men with benign prostatic hyperplasia. J Urol 167(2 Pt 2):1102\u20131107; discussion 1108", "journal-title": "J Urol"}, {"issue": "4", "key": "7_CR13_7", "doi-asserted-by": "publisher", "first-page": "670", "DOI": "10.1016/j.urology.2004.10.077", "volume": "65", "author": "HC Kuo", "year": "2005", "unstructured": "Kuo HC (2005) Prostate botulinum A toxin injection\u2013an alternative treatment for benign prostatic obstruction in poor surgical candidates. Urology 65(4):670\u2013674", "journal-title": "Urology"}, {"issue": "5", "key": "7_CR14_7", "doi-asserted-by": "crossref", "first-page": "1336", "DOI": "10.1016/S0022-5347(17)43594-4", "volume": "138", "author": "H Lepor", "year": "1987", "unstructured": "Lepor H, Baumann M, Shapiro E (1987) Identification and characterization of alpha 1 adrenergic receptors in the canine prostate using [125I]-Heat. J Urol 138(5):1336\u20131339", "journal-title": "J Urol"}, {"issue": "4", "key": "7_CR15_7", "doi-asserted-by": "publisher", "first-page": "700", "DOI": "10.1016/j.eururo.2008.04.037", "volume": "56", "author": "HT Liu", "year": "2009", "unstructured": "Liu HT, Chancellor MB, Kuo HC (2009) Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol 56(4):700\u2013706", "journal-title": "Eur Urol"}, {"issue": "9128", "key": "7_CR16_7", "doi-asserted-by": "publisher", "first-page": "625", "DOI": "10.1016/S0140-6736(05)79580-5", "volume": "352", "author": "G Maria", "year": "1998", "unstructured": "Maria G, Destito A, Lacquaniti S, Bentivoglio AR, Brisinda G, Albanese A (1998) Relief by botulinum toxin of voiding dysfunction due to prostatitis. Lancet 352(9128):625", "journal-title": "Lancet"}, {"issue": "2", "key": "7_CR17_7", "doi-asserted-by": "publisher", "first-page": "259", "DOI": "10.1016/S0090-4295(03)00477-1", "volume": "62", "author": "G Maria", "year": "2003", "unstructured": "Maria G, Brisinda G, Civello IM, Bentivoglio AR, Sganga G, Albanese A (2003) Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urology 62(2):259\u2013264; discussion 264\u2013265", "journal-title": "Urology"}, {"issue": "5 Suppl", "key": "7_CR18_7", "first-page": "S122", "volume": "12", "author": "KT McVary", "year": "2006", "unstructured": "McVary KT (2006) BPH: epidemiology and comorbidities. Am J Manag Care 12(5 Suppl):S122\u2013S128", "journal-title": "Am J Manag Care"}, {"issue": "1", "key": "7_CR19_7", "doi-asserted-by": "publisher", "first-page": "99", "DOI": "10.1095/biolreprod51.1.99", "volume": "51", "author": "KT McVary", "year": "1994", "unstructured": "McVary KT, Razzaq A, Lee C, Venegas MF, Rademaker A, McKenna KE (1994) Growth of the rat prostate gland is facilitated by the autonomic nervous system. Biol Reprod 51(1):99\u2013107", "journal-title": "Biol Reprod"}, {"issue": "suppl", "key": "7_CR20_7", "doi-asserted-by": "publisher", "first-page": "690", "DOI": "10.1016/j.juro.2010.02.1691", "volume": "183", "author": "K McVary", "year": "2010", "unstructured": "McVary K, Crawford D, Donnel R, Drews K, Kaplan S, Kusek J, Roehborn C, Bruskewitz R (2010) MIST_2: baseline PSA and total prostate volume predicts clinical response to intraprostatic injection of botulinum toxin for the treatment of LUTS. J Urol 183(suppl):690", "journal-title": "J Urol"}, {"issue": "10", "key": "7_CR21_7", "doi-asserted-by": "publisher", "first-page": "1547", "DOI": "10.1111/j.1742-1241.2008.01880.x", "volume": "62", "author": "JC Nickel", "year": "2008", "unstructured": "Nickel JC, Sander S, Moon TD (2008) A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia. Int J Clin Pract 62(10):1547\u20131559", "journal-title": "Int J Clin Pract"}, {"issue": "3", "key": "7_CR22_7", "doi-asserted-by": "publisher", "first-page": "151", "DOI": "10.3109/00365591003649201", "volume": "44", "author": "M Nikoobakht", "year": "2010", "unstructured": "Nikoobakht M, Daneshpajooh A, Ahmadi H, Namdari F, Rezaeidanesh M, Amini S, Pourmand G (2010) Intraprostatic botulinum toxin type A injection for the treatment of benign prostatic hyperplasia: initial experience with Dysport. Scand J Urol Nephrol 44(3):151\u2013157", "journal-title": "Scand J Urol Nephrol"}, {"issue": "4", "key": "7_CR23_7", "doi-asserted-by": "publisher", "first-page": "765", "DOI": "10.1016/j.eururo.2008.06.016", "volume": "54", "author": "A Oeconomou", "year": "2008", "unstructured": "Oeconomou A, Madersbacher H, Kiss G, Berger TJ, Melekos M, Rehder P (2008) Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature. Eur Urol 54(4):765\u2013775", "journal-title": "Eur Urol"}, {"key": "7_CR24_7", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1186/1471-2490-9-9", "volume": "9", "author": "J Silva", "year": "2009", "unstructured": "Silva J, Pinto R, Carvalho T, Botelho F, Silva P, Oliveira R, Silva C, Cruz F, Dinis P (2009a) Intraprostatic botulinum toxin type A injection in patients with benign prostatic enlargement: duration of the effect of a single treatment. BMC Urol 9:9", "journal-title": "BMC Urol"}, {"issue": "1", "key": "7_CR25_7", "doi-asserted-by": "publisher", "first-page": "134", "DOI": "10.1016/j.eururo.2008.07.003", "volume": "56", "author": "J Silva", "year": "2009", "unstructured": "Silva J, Pinto R, Carvallho T, Coelho A, Avelino A, Dinis P, Cruz F (2009b) Mechanisms of prostate atrophy after glandular botulinum neurotoxin type a injection: an experimental study in the rat. Eur Urol 56(1):134\u2013140", "journal-title": "Eur Urol"}, {"issue": "5", "key": "7_CR26_7", "doi-asserted-by": "publisher", "first-page": "639", "DOI": "10.1016/j.toxicon.2009.02.021", "volume": "54", "author": "CP Smith", "year": "2009", "unstructured": "Smith CP (2009) Botulinum toxin in the treatment of OAB, BPH, and IC. Toxicon 54(5):639\u2013646", "journal-title": "Toxicon"}, {"issue": "5", "key": "7_CR27_7", "doi-asserted-by": "publisher", "first-page": "539", "DOI": "10.1016/S0302-2838(03)00376-2", "volume": "44", "author": "KM Verhamme", "year": "2003", "unstructured": "Verhamme KM, Dieleman JP, Bleumink GS, Bosch JL, Stricker BH, Sturkenboom MC (2003) Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project. Eur Urol 44(5):539\u2013545", "journal-title": "Eur Urol"}, {"issue": "4", "key": "7_CR28_7", "doi-asserted-by": "publisher", "first-page": "1256", "DOI": "10.1097/01.ju.0000155709.37840.fe", "volume": "173", "author": "JT Wei", "year": "2005", "unstructured": "Wei JT, Calhoun E, Jacobsen SJ (2005) Urologic diseases in America project: benign prostatic hyperplasia. J Urol 173(4):1256\u20131261", "journal-title": "J Urol"}, {"issue": "4", "key": "7_CR29_7", "doi-asserted-by": "publisher", "first-page": "393", "DOI": "10.1159/000020314", "volume": "38", "author": "D Zermann", "year": "2000", "unstructured": "Zermann D, Ishigooka M, Schubert J, Schmidt RA (2000) Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain? Eur Urol 38(4):393\u2013399", "journal-title": "Eur Urol"}], "container-title": ["Botulinum Toxin in Urology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-642-03580-7_7", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 29]], "date-time": "2019-03-29T09:13:40Z", "timestamp": 1553850820000}, "score": 26.736238, "issued": {"date-parts": [[2011]]}, "ISBN": ["9783642035791", "9783642035807"], "references-count": 29, "URL": "http://dx.doi.org/10.1007/978-3-642-03580-7_7", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T03:45:33Z", "timestamp": 1574567133967}, "publisher-location": "New York, NY", "reference-count": 0, "publisher": "Springer New York", "isbn-type": [{"value": "9781493915439", "type": "print"}, {"value": "9781493915446", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2015]]}, "DOI": "10.1007/978-1-4939-1544-6_135", "type": "book-chapter", "created": {"date-parts": [[2014, 12, 10]], "date-time": "2014-12-10T06:56:32Z", "timestamp": 1418194592000}, "page": "435-435", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Botulinum Toxin Therapy for Hyperhidrosis: How I Do It"], "prefix": "10.1007", "author": [{"given": "Charles B.", "family": "Slonim", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2014, 11, 25]]}, "container-title": ["Pearls and Pitfalls in Cosmetic Oculoplastic Surgery"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4939-1544-6_135", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2014, 12, 10]], "date-time": "2014-12-10T06:56:59Z", "timestamp": 1418194619000}, "score": 26.534084, "issued": {"date-parts": [[2014, 11, 25]]}, "ISBN": ["9781493915439", "9781493915446"], "references-count": 0, "URL": "http://dx.doi.org/10.1007/978-1-4939-1544-6_135"}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T05:52:56Z", "timestamp": 1574401976803}, "publisher-location": "Cambridge", "reference-count": 0, "publisher": "Cambridge University Press", "isbn-type": [{"value": "9780521694421", "type": "print"}, {"value": "9780511575761", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1017/cbo9780511575761.021", "type": "book-chapter", "created": {"date-parts": [[2009, 12, 24]], "date-time": "2009-12-24T12:47:19Z", "timestamp": 1261658839000}, "page": "161-174", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Use of botulinum toxin in musculoskeletal pain and arthritis"], "prefix": "10.1017", "author": [{"given": "Amy M.", "family": "Lang", "sequence": "first", "affiliation": []}], "member": "56", "container-title": ["Manual of Botulinum Toxin Therapy"], "deposited": {"date-parts": [[2018, 4, 13]], "date-time": "2018-04-13T04:48:37Z", "timestamp": 1523594917000}, "score": 26.189367, "editor": [{"given": "Daniel", "family": "Truong", "sequence": "additional", "affiliation": []}, {"given": "Dirk", "family": "Dressler", "sequence": "additional", "affiliation": []}, {"given": "Mark", "family": "Hallett", "sequence": "additional", "affiliation": []}], "issued": {"date-parts": [[null]]}, "ISBN": ["9780511575761", "9780521694421"], "references-count": 0, "URL": "http://dx.doi.org/10.1017/cbo9780511575761.021"}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T17:42:26Z", "timestamp": 1574444546312}, "reference-count": 0, "publisher": "Medicina Oral, S.L.", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Med Oral"], "published-print": {"date-parts": [[2010]]}, "DOI": "10.4317/medoral.15.e649", "type": "journal-article", "created": {"date-parts": [[2010, 7, 12]], "date-time": "2010-07-12T10:20:09Z", "timestamp": 1278930009000}, "page": "e649-e652", "source": "Crossref", "is-referenced-by-count": 19, "title": ["Treatment of masseteric hypertrophy with botulinum toxin: A report of two cases"], "prefix": "10.4317", "author": [{"given": "B.", "family": "Bas", "sequence": "first", "affiliation": []}, {"given": "B.", "family": "Ozan", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Muglali", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Celebi", "sequence": "additional", "affiliation": []}], "member": "2883", "container-title": ["Medicina Oral Patolog\u00eda Oral y Cirugia Bucal"], "deposited": {"date-parts": [[2010, 7, 12]], "date-time": "2010-07-12T10:20:30Z", "timestamp": 1278930030000}, "score": 26.0401, "issued": {"date-parts": [[2010]]}, "references-count": 0, "URL": "http://dx.doi.org/10.4317/medoral.15.e649", "ISSN": ["1698-6946"], "issn-type": [{"value": "1698-6946", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T03:34:23Z", "timestamp": 1574825663202}, "publisher-location": "Cham", "reference-count": 90, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319560373", "type": "print"}, {"value": "9783319560380", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2017, 8, 24]], "date-time": "2017-08-24T00:00:00Z", "timestamp": 1503532800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018]]}, "DOI": "10.1007/978-3-319-56038-0_9", "type": "book-chapter", "created": {"date-parts": [[2017, 8, 23]], "date-time": "2017-08-23T06:50:47Z", "timestamp": 1503471047000}, "page": "145-165", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Botulinum Toxin Treatment of Migraine and Other Headaches"], "prefix": "10.1007", "author": [{"given": "Sara M.", "family": "Schaefer", "sequence": "first", "affiliation": []}, {"given": "Bahman", "family": "Jabbari", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2017, 8, 24]]}, "reference": [{"key": "9_CR1", "author": "World Health Organization", "first-page": "31", "year": "2008", "unstructured": "World Health Organization. The global burden of disease: 2004 update. Geneva, Switzerland: WHO Press; 2008. p. 31.", "volume-title": "The global burden of disease: 2004 update"}, {"issue": "Suppl 1", "key": "9_CR2", "first-page": "9", "volume": "24", "author": "Headache Classification Subcommittee of the International Headache, S", "year": "2004", "unstructured": "Headache Classification Subcommittee of the International Headache, S. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004;24(Suppl 1):9\u2013160.", "journal-title": "Cephalalgia"}, {"key": "9_CR3", "unstructured": "Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, Group, A.A. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343\u2013349.", "DOI": "10.1212/01.wnl.0000252808.97649.21", "doi-asserted-by": "crossref"}, {"key": "9_CR4", "doi-asserted-by": "crossref", "first-page": "1280", "DOI": "10.1111/head.12878", "volume": "56", "author": "RB Lipton", "year": "2016", "unstructured": "Lipton RB, Manack Adams A, Buse DC, Fanning KM, Reed ML, Headache A. Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: demographics and headache-related disability. Headache. 2016;56:1280\u20139.", "journal-title": "Headache"}, {"key": "9_CR5", "first-page": "S62", "volume": "11", "author": "LD Goldberg", "year": "2005", "unstructured": "Goldberg LD. The cost of migraine and its treatment. Am J Manag Care. 2005;11:S62\u20137.", "journal-title": "Am J Manag Care"}, {"issue": "Suppl 1", "key": "9_CR6", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1007/s10072-014-1741-5", "volume": "35", "author": "M Ruggeri", "year": "2014", "unstructured": "Ruggeri M. The cost effectiveness of botox in italian patients with chronic migraine. Neurol Sci. 2014;35(Suppl 1):45\u20137.", "journal-title": "Neurol Sci"}, {"key": "9_CR7", "doi-asserted-by": "crossref", "first-page": "548", "DOI": "10.1001/archneur.56.5.548", "volume": "56", "author": "Y Cao", "year": "1999", "unstructured": "Cao Y, Welch KM, Aurora S, Vikingstad EM. Functional mri-bold of visually triggered headache in patients with migraine. Arch Neurol. 1999;56:548\u201354.", "journal-title": "Arch Neurol"}, {"key": "9_CR8", "doi-asserted-by": "crossref", "first-page": "S9", "DOI": "10.1212/WNL.61.8_suppl_4.S9", "volume": "61", "author": "C Waeber", "year": "2003", "unstructured": "Waeber C, Moskowitz MA. Therapeutic implications of central and peripheral neurologic mechanisms in migraine. Neurology. 2003;61:S9\u201320.", "journal-title": "Neurology"}, {"key": "9_CR9", "unstructured": "Noseda R, Burstein R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, csd, sensitization and modulation of pain. Pain 2013;154(Suppl 1):S44\u2013S53.", "DOI": "10.1016/j.pain.2013.07.021", "doi-asserted-by": "crossref"}, {"key": "9_CR10", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1186/1129-2377-14-71", "volume": "14", "author": "S Benemei", "year": "2013", "unstructured": "Benemei S, De Cesaris F, Fusi C, Rossi E, Lupi C, Geppetti P. Trpa1 and other trp channels in migraine. J Headache Pain. 2013;14:71.", "journal-title": "J Headache Pain"}, {"key": "9_CR11", "unstructured": "Del Fiacco M, Quartu M, Boi M, Serra MP, Melis T, Boccaletti R, Shevel E, Cianchetti C. Trpv1, cgrp and sp in scalp arteries of patients suffering from chronic migraine. J Neurol Neurosurg Psychiatry. 2015;86:393\u2013397.", "DOI": "10.1136/jnnp-2014-308813", "doi-asserted-by": "crossref"}, {"key": "9_CR12", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1002/ana.10786", "volume": "55", "author": "R Burstein", "year": "2004", "unstructured": "Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol. 2004;55:19\u201326.", "journal-title": "Ann Neurol"}, {"key": "9_CR13", "doi-asserted-by": "crossref", "first-page": "1191", "DOI": "10.1212/WNL.0b013e3182a6cb72", "volume": "81", "author": "E Cernuda-Morollon", "year": "2013", "unstructured": "Cernuda-Morollon E, Larrosa D, Ramon C, Vega J, Martinez-Camblor P, Pascual J. Interictal increase of cgrp levels in peripheral blood as a biomarker for chronic migraine. Neurology. 2013;81:1191\u20136.", "journal-title": "Neurology"}, {"key": "9_CR14", "doi-asserted-by": "crossref", "first-page": "482", "DOI": "10.1038/ncpneuro0861", "volume": "4", "author": "SD Silberstein", "year": "2008", "unstructured": "Silberstein SD. Treatment recommendations for migraine. Nat Clin Pract Neurol. 2008;4:482\u20139.", "journal-title": "Nat Clin Pract Neurol"}, {"key": "9_CR15", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1007/s11916-010-0159-x", "volume": "15", "author": "HC Diener", "year": "2011", "unstructured": "Diener HC, Holle D, Dodick D. Treatment of chronic migraine. Curr Pain Headache Rep. 2011;15:64\u20139.", "journal-title": "Curr Pain Headache Rep"}, {"key": "9_CR16", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1007/s40263-013-0126-2", "volume": "28", "author": "J Hoffmann", "year": "2014", "unstructured": "Hoffmann J, Goadsby PJ. Emerging targets in migraine. CNS Drugs. 2014;28:11\u20137.", "journal-title": "CNS Drugs"}, {"key": "9_CR17", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1177/1941874412439583", "volume": "2", "author": "AA Gelfand", "year": "2012", "unstructured": "Gelfand AA, Goadsby PJ. A neurologist\u2019s guide to acute migraine therapy in the emergency room. Neurohospitalist. 2012;2:51\u20139.", "journal-title": "Neurohospitalist"}, {"key": "9_CR18", "unstructured": "Ozkurt B, Cinar O, Cevik E, Acar AY, Arslan D, Eyi EY, Jay L, Yamanel L, Madsen T. Efficacy of high-flow oxygen therapy in all types of headache: a prospective, randomized, placebo-controlled trial. Am J Emerg Med. 2012;30:1760\u20131764.", "DOI": "10.1016/j.ajem.2012.02.010", "doi-asserted-by": "crossref"}, {"key": "9_CR19", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1046/j.1468-2982.1997.1702067.x", "volume": "17", "author": "SD Silberstein", "year": "1997", "unstructured": "Silberstein SD. Preventive treatment of migraine: an overview. Cephalalgia. 1997;17:67\u201372.", "journal-title": "Cephalalgia"}, {"key": "9_CR20", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1002/ana.23996", "volume": "74", "author": "PJ Goadsby", "year": "2013", "unstructured": "Goadsby PJ. Therapeutic prospects for migraine: can paradise be regained? Ann Neurol. 2013;74:423\u201334.", "journal-title": "Ann Neurol"}, {"key": "9_CR21", "unstructured": "Schoenen J, Vandersmissen B, Jeangette S, Herroelen L, Vandenheede M, Gerard P, Magis D. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013;80:697\u2013704.", "DOI": "10.1212/WNL.0b013e3182825055", "doi-asserted-by": "crossref"}, {"key": "9_CR22", "doi-asserted-by": "crossref", "first-page": "621", "DOI": "10.1038/nrneurol.2015.203", "volume": "11", "author": "P Goadsby", "year": "2015", "unstructured": "Goadsby P. Decade in reviewmigraine: incredible progress for an era of better migraine care. Nat Rev Neurol. 2015;11:621\u20132.", "journal-title": "Nat Rev Neurol"}, {"key": "9_CR23", "unstructured": "Bigal ME, Dodick DW, Krymchantowski A.V, VanderPluym JH, Tepper SJ, Aycardi E, Loupe PS, Ma Y, Goadsby PJ. TEV-48125 for the preventive treatment of chronic migraine: efficacy at early time points. Neurology. 2016;87:41\u201348.", "DOI": "10.1212/WNL.0000000000002801", "doi-asserted-by": "crossref"}, {"key": "9_CR24", "unstructured": "Sun H, Dodick DW, Silberstein S, Goadsby PJ, Reuter U, Ashina M, Saper J, Cady R, Chon Y, Dietrich J, Lenz R. Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomized, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2016;15:382\u2013390.", "DOI": "10.1016/S1474-4422(16)00019-3", "doi-asserted-by": "crossref"}, {"key": "9_CR25", "doi-asserted-by": "crossref", "first-page": "785", "DOI": "10.1016/j.neuro.2005.01.017", "volume": "26", "author": "KR Aoki", "year": "2006", "unstructured": "Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2006;26:785\u201393.", "journal-title": "Neurotoxicology"}, {"key": "9_CR26", "doi-asserted-by": "crossref", "first-page": "2864", "DOI": "10.1242/jcs.012211", "volume": "120", "author": "J Meng", "year": "2007", "unstructured": "Meng J, Wang J, Lawrence G, Dolly JO. Synaptobrevin i mediates exocytosis of cgrp from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential. J Cell Sci. 2007;120:2864\u201374.", "journal-title": "J Cell Sci"}, {"key": "9_CR27", "doi-asserted-by": "crossref", "first-page": "366", "DOI": "10.1111/j.1464-410X.2007.07312.x", "volume": "101", "author": "A Lucioni", "year": "2008", "unstructured": "Lucioni A, Bales GT, Lotan TL, McGehee DS, Cook SP, Rapp DE. Botulinum toxin type a inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int. 2008;101:366\u201370.", "journal-title": "BJU Int"}, {"key": "9_CR28", "unstructured": "Shimizu T, Shibata M, Toriumi H, Iwashita T, Funakubo M, Sato H, Kuroi T, Ebine T, Koizumi K, Suzuki N. Reduction of trpv1 expression in the trigeminal system by botulinum neurotoxin type-a. Neurobiol Dis. 2012;48:367\u2013378.", "DOI": "10.1016/j.nbd.2012.07.010", "doi-asserted-by": "crossref"}, {"key": "9_CR29", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1016/j.toxicon.2014.12.007", "volume": "94", "author": "S Luvisetto", "year": "2015", "unstructured": "Luvisetto S, Vacca V, Cianchetti C. Analgesic effects of botulinum neurotoxin type a in a model of allyl isothiocyanate- and capsaicin-induced pain in mice. Toxicon. 2015;94:23\u20138.", "journal-title": "Toxicon"}, {"key": "9_CR30", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1016/j.pain.2003.10.008", "volume": "107", "author": "M Cui", "year": "2004", "unstructured": "Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin a reduces formalin-induced pain. Pain. 2004;107:125\u201333.", "journal-title": "Pain"}, {"key": "9_CR31", "doi-asserted-by": "crossref", "first-page": "674", "DOI": "10.1016/j.pain.2013.12.009", "volume": "155", "author": "MJ Marino", "year": "2014", "unstructured": "Marino MJ, Terashima T, Steinauer JJ, Eddinger KA, Yaksh TL, Xu Q. Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior. Pain. 2014;155:674\u201384.", "journal-title": "Pain"}, {"key": "9_CR32", "doi-asserted-by": "crossref", "first-page": "588", "DOI": "10.1038/206588a0", "volume": "206", "author": "MJ Rand", "year": "1965", "unstructured": "Rand MJ, Whaler BC. Impairment of sympathetic transmission by botulinum toxin. Nature. 1965;206:588\u201391.", "journal-title": "Nature"}, {"key": "9_CR33", "doi-asserted-by": "crossref", "first-page": "400", "DOI": "10.3109/00016489309135834", "volume": "113", "author": "GM Filippi", "year": "1993", "unstructured": "Filippi GM, Errico P, Santarelli R, Bagolini B, Manni E. Botulinum a toxin effects on rat jaw muscle spindles. Acta Otolaryngol. 1993;113:400\u20134.", "journal-title": "Acta Otolaryngol"}, {"key": "9_CR34", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1016/j.ejphar.2010.01.020", "volume": "633", "author": "L Bach-Rojecky", "year": "2010", "unstructured": "Bach-Rojecky L, Salkovic-Petrisic M, Lackovic Z. Botulinum toxin type a reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection. Eur J Pharmacol. 2010;633:10\u20134.", "journal-title": "Eur J Pharmacol"}, {"key": "9_CR35", "unstructured": "Shin MC, Wakita, M, Xie, DJ, Yamaga T, Iwata S, Torii Y, Harakawa T, Ginnaga A, Kozaki S, Akaike N. Inhibition of membrane Na+ channels by A type botulinum toxin at femtomolar concentrations in central and peripheral neurons. J Pharmacol Sci. 2012;118:33\u201342.", "DOI": "10.1254/jphs.11060FP", "doi-asserted-by": "crossref"}, {"key": "9_CR36", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1016/j.neuroscience.2011.04.026", "volume": "186", "author": "I Matak", "year": "2011", "unstructured": "Matak I, Bach-Rojecky L, Filipovic B, Lackovic Z. Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin a. Neuroscience. 2011;186:201\u20137.", "journal-title": "Neuroscience"}, {"key": "9_CR37", "doi-asserted-by": "crossref", "first-page": "236", "DOI": "10.1016/j.neuint.2012.05.001", "volume": "61", "author": "I Matak", "year": "2012", "unstructured": "Matak I, Riederer P, Lackovic Z. Botulinum toxin's axonal transport from periphery to the spinal cord. Neurochem Int. 2012;61:236\u20139.", "journal-title": "Neurochem Int"}, {"key": "9_CR38", "unstructured": "Marinelli S, Vacca V, Ricordy R, Uggenti C, Tata, AM, Luvisetto S, Pavone F. The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin a involves schwann cells and astrocytes. PLoS One. 2012;7:e47977.", "DOI": "10.1371/journal.pone.0047977", "doi-asserted-by": "crossref"}, {"key": "9_CR39", "doi-asserted-by": "crossref", "first-page": "853", "DOI": "10.1177/0333102414527648", "volume": "34", "author": "R Burstein", "year": "2014", "unstructured": "Burstein R, Zhang X, Levy D, Aoki KR, Brin MF. Selective inhibition of meningeal nociceptors by botulinum neurotoxin type a: therapeutic implications for migraine and other pains. Cephalalgia. 2014;34:853\u201369.", "journal-title": "Cephalalgia"}, {"key": "9_CR40", "first-page": "781", "volume": "24", "author": "M Orinsky", "year": "2004", "unstructured": "Orinsky M, Poso-Rosich P, Luo J, Hayman S, Silberstein SD. Botulinum toxin a blocks sensitization of neurons in trigeminal nucleus caudalis. Cephalalgia. 2004;24:781.", "journal-title": "Cephalalgia"}, {"key": "9_CR41", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1046/j.1526-4610.2000.00066.x", "volume": "40", "author": "S Silberstein", "year": "2000", "unstructured": "Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type a as a migraine preventive treatment. For the botox migraine clinical research group. Headache. 2000;40:445\u201350.", "journal-title": "Headache"}, {"key": "9_CR42", "unstructured": "Dodick D, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein S, Group, B.C.S. Botulinum toxin type a for the prophylaxis of chronic daily headache: a subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache. 2005;45:315\u2013324.", "DOI": "10.1111/j.1526-4610.2005.05068.x", "doi-asserted-by": "crossref"}, {"key": "9_CR43", "first-page": "201", "volume": "48", "author": "FG Freitag", "year": "2008", "unstructured": "Freitag FG, Diamond S, Diamond M, Urban G. Botulinum toxin type a in the treatment of chronic migraine without medication overuse. Headache. 2008;48:201\u20139.", "journal-title": "Headache"}, {"key": "9_CR44", "unstructured": "Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF, Group, P.C.M.S. Onabotulinumtoxina for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the preempt 1 trial. Cephalalgia. 2010;30:793\u2013803.", "DOI": "10.1177/0333102410364676", "doi-asserted-by": "crossref"}, {"key": "9_CR45", "unstructured": "Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, Silberstein SD, Brin MF, Group, P.C.M.S. Onabotulinumtoxina for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the preempt 2 trial. Cephalalgia. 2010;30:804\u2013814.", "DOI": "10.1177/0333102410364677", "doi-asserted-by": "crossref"}, {"key": "9_CR46", "unstructured": "Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, Group, P.C.M.S. Onabotulinumtoxina for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the preempt clinical program. Headache. 2010;50:921\u2013936.", "DOI": "10.1111/j.1526-4610.2010.01678.x", "doi-asserted-by": "crossref"}, {"key": "9_CR47", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1186/1129-2377-15-54", "volume": "15", "author": "M Khalil", "year": "2014", "unstructured": "Khalil M, Zafar HW, Quarshie V, Ahmed F. Prospective analysis of the use of onabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, U.K. J Headache Pain. 2014;15:54.", "journal-title": "J Headache Pain"}, {"key": "9_CR48", "doi-asserted-by": "crossref", "first-page": "1466", "DOI": "10.1111/j.1526-4610.2009.01566.x", "volume": "49", "author": "NT Mathew", "year": "2009", "unstructured": "Mathew NT, Jaffri SF. A double-blind comparison of onabotulinumtoxina (botox) and topiramate (topamax) for the prophylactic treatment of chronic migraine: a pilot study. Headache. 2009;49:1466\u201378.", "journal-title": "Headache"}, {"key": "9_CR49", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1111/j.1526-4610.2010.01796.x", "volume": "51", "author": "RK Cady", "year": "2011", "unstructured": "Cady RK, Schreiber CP, Porter JA, Blumenfeld AM, Farmer KU. A multi-center double-blind pilot comparison of onabotulinumtoxina and topiramate for the prophylactic treatment of chronic migraine. Headache. 2011;51:21\u201332.", "journal-title": "Headache"}, {"key": "9_CR50", "doi-asserted-by": "crossref", "first-page": "210", "DOI": "10.1111/j.1526-4610.2007.00949.x", "volume": "48", "author": "AM Blumenfeld", "year": "2008", "unstructured": "Blumenfeld AM, Schim JD, Chippendale TJ. Botulinum toxin type a and divalproex sodium for prophylactic treatment of episodic or chronic migraine. Headache. 2008;48:210\u201320.", "journal-title": "Headache"}, {"key": "9_CR51", "unstructured": "Silberstein S.D, Blumenfeld AM, Cady RK, Turner IM, Lipton RB, Diener HC, Aurora SK, Sirimanne M, DeGryse RE, Turkel CC, et al.. Onabotulinumtoxina for treatment of chronic migraine: preempt 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline. J Neurol Sci. 2013;331:48\u201356.", "DOI": "10.1016/j.jns.2013.05.003", "doi-asserted-by": "crossref"}, {"key": "9_CR52", "unstructured": "Aurora SK, Dodick DW, Diener HC, DeGryse RE, Turkel CC, Lipton RB, Silberstein SD. Onabotulinumtoxina for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the preempt clinical program. Acta Neurol Scand. 2014;129:61\u201370.", "DOI": "10.1111/ane.12171", "doi-asserted-by": "crossref"}, {"key": "9_CR53", "unstructured": "Silberstein SD, Dodick DW, Aurora SK, Diener HC, DeGryse, RE, Lipton, RB, Turkel CC. Percent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT. J Neurol Neurosurg Psychiatry. 2015;86:996\u20131001.", "DOI": "10.1136/jnnp-2013-307149", "doi-asserted-by": "crossref"}, {"key": "9_CR54", "doi-asserted-by": "crossref", "first-page": "286", "DOI": "10.1016/j.pain.2006.09.012", "volume": "125", "author": "M Jakubowski", "year": "2006", "unstructured": "Jakubowski M, McAllister PJ, Bajwa ZH, Ward TN, Smith P, Burstein R. Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A. Pain. 2006;125:286\u201395.", "journal-title": "Pain"}, {"key": "9_CR55", "doi-asserted-by": "crossref", "first-page": "884", "DOI": "10.1046/j.1526-4610.2003.03167.x", "volume": "43", "author": "AM Blumenfeld", "year": "2003", "unstructured": "Blumenfeld AM, Binder W, Silberstein SD, Blitzer A. Procedures for administering botulinum toxin type a for migraine and tension-type headache. Headache. 2003;43:884\u201391.", "journal-title": "Headache"}, {"key": "9_CR56", "first-page": "218", "volume-title": "Botulinum toxin in headache management. Botulinum toxin: therapeutic clinical practice and science", "author": "SD Silberstein", "year": "2009", "unstructured": "Silberstein SD. Botulinum toxin in headache management. Botulinum toxin: therapeutic clinical practice and science. 1st ed. Philadelphia, PA: Saunders, Elsevier; 2009. p. 218.", "edition": "1"}, {"key": "9_CR57", "doi-asserted-by": "crossref", "first-page": "1406", "DOI": "10.1111/j.1526-4610.2010.01766.x", "volume": "50", "author": "A Blumenfeld", "year": "2010", "unstructured": "Blumenfeld A, Silberstein SD, Dodick DW, Aurora SK, Turkel CC, Binder WJ. Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program. Headache. 2010;50:1406\u201318.", "journal-title": "Headache"}, {"key": "9_CR58", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.3390/toxins8090265", "volume": "8", "author": "YJ Choi", "year": "2016", "unstructured": "Choi YJ, Lee WJ, Lee HJ, Lee KW, Kim HJ, Hu KS. Effective botulinum toxin guide for treatment of temporal headache. Toxins. 2016;8:265.", "journal-title": "Toxins"}, {"key": "9_CR59", "doi-asserted-by": "crossref", "first-page": "2615", "DOI": "10.3390/toxins7072615", "volume": "7", "author": "SM Schaefer", "year": "2015", "unstructured": "Schaefer SM, Gottschalk C, Jabbari B. Treatment of chronic migraine with focus on botulinum toxins. Toxins. 2015;7:2615\u201328.", "journal-title": "Toxins"}, {"key": "9_CR60", "unstructured": "Richardson D, Jabbari B. Botulinum toxin treatment of chronic migraine: a double blind study with a novel technique employing fewer injections. Poster 124th American Academy of Neurology annual meeting, Vancouver, Canada, April 19, 2016."}, {"key": "9_CR61", "doi-asserted-by": "crossref", "first-page": "838", "DOI": "10.1111/j.1468-2982.2004.00754.x", "volume": "24", "author": "S Evers", "year": "2004", "unstructured": "Evers S, Vollmer-Haase J, Schwaag S, Rahmann A, Husstedt IW, Frese A. Botulinum toxin A in the prophylactic treatment of migraine--a randomized, double-blind, placebo-controlled study. Cephalalgia. 2004;24:838\u201343.", "journal-title": "Cephalalgia"}, {"key": "9_CR62", "doi-asserted-by": "crossref", "first-page": "688", "DOI": "10.1016/j.jpain.2006.03.002", "volume": "7", "author": "AH Elkind", "year": "2006", "unstructured": "Elkind AH, O\u2019Carroll P, Blumenfeld A, DeGryse R, Dimitrova R, BoNTA-024-026-036 Study Group. A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxis. J Pain. 2006;7:688\u201396.", "journal-title": "J Pain"}, {"key": "9_CR63", "unstructured": "Saper JR, Mathew NT, Loder EW, DeGryse R, VanDenburgh AM, BoNTA-009 Study Group. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine. Pain Med. 2007;8:478\u201385.", "DOI": "10.1111/j.1526-4637.2006.00168.x", "doi-asserted-by": "crossref"}, {"key": "9_CR64", "doi-asserted-by": "crossref", "first-page": "492", "DOI": "10.1111/j.1468-2982.2007.01315.x", "volume": "27", "author": "M Relja", "year": "2007", "unstructured": "Relja M, Poole AC, Schoenen J, Pascual J, Lei X, Thompson C. A multicentre, double- blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches. Cephalalgia. 2007;27:492\u2013503.", "journal-title": "Cephalalgia"}, {"key": "9_CR65", "doi-asserted-by": "crossref", "first-page": "486", "DOI": "10.1111/j.1526-4610.2007.00853.x", "volume": "47", "author": "SK Aurora", "year": "2007", "unstructured": "Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group. Botulinum toxin type A prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. Headache. 2007;47:486\u201399.", "journal-title": "Headache"}, {"key": "9_CR66", "unstructured": "Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, Armstrong, MJ, Gloss D, Potrebic S, Jankovic J, Karp BP, Naumann M, So YT, Yablon SA. Practice guideline update summary: botulinum neurotoxin for the treatment ofblepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016;86:1818\u201326.", "DOI": "10.1212/WNL.0000000000002560", "doi-asserted-by": "crossref"}, {"key": "9_CR67", "doi-asserted-by": "crossref", "first-page": "381", "DOI": "10.1001/jama.279.5.381", "volume": "279", "author": "BS Schwartz", "year": "1998", "unstructured": "Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA. 1998;279:381\u20133.", "journal-title": "JAMA"}, {"key": "9_CR68", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1046/j.1468-2982.1996.1602097.x", "volume": "16", "author": "R Jensen", "year": "1996", "unstructured": "Jensen R, Rasmussen BK. Muscular disorders in tension-type headache. Cephalalgia. 1996;16:97\u2013103.", "journal-title": "Cephalalgia"}, {"key": "9_CR69", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1016/j.mcna.2012.12.003", "volume": "97", "author": "F Freitag", "year": "2013", "unstructured": "Freitag F. Managing and treating tension-type headache. Med Clin North Am. 2013;97:281\u201392.", "journal-title": "Med Clin North Am"}, {"key": "9_CR70", "first-page": "99", "volume-title": "The practicing physician\u2019s approach to headache", "author": "S Diamond", "year": "1986", "unstructured": "Diamond S, Dalessio DJ. Muscle contraction headache. In: Diamond D, Dalessio DJ, editors. The practicing physician\u2019s approach to headache. 4th ed. Baltimore, MD: Williams and Wilkins; 1986. p. 99\u2013113.", "edition": "4th"}, {"key": "9_CR71", "doi-asserted-by": "crossref", "first-page": "1318", "DOI": "10.1111/j.1468-1331.2010.03070.x", "volume": "17", "author": "L Bendtsen", "year": "2010", "unstructured": "Bendtsen L, Evers S, Linde M, Mitsikostas DD, Sandrini G, Schoenen J. FNS guideline on the treatment of tension-type headache\u2014report of an EFNS task force. Eur J Neurol. 2010;17:1318\u201325.", "journal-title": "Eur J Neurol"}, {"key": "9_CR72", "doi-asserted-by": "crossref", "first-page": "658", "DOI": "10.1046/j.1526-4610.2001.041007658.x", "volume": "41", "author": "WJ Schmitt", "year": "2001", "unstructured": "Schmitt WJ, Slowey E, Fravi N, Weber S, Burgunder JM. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache. 2001;41:658\u201364.", "journal-title": "Headache"}, {"key": "9_CR73", "first-page": "123", "volume": "79", "author": "JD Rollnik", "year": "2002", "unstructured": "Rollnik JD, Dengler R. Botulinum toxin (DYSPORT) in tension-type headaches. Acta Neurochir Suppl. 2002;79:123\u20136.", "journal-title": "Acta Neurochir Suppl"}, {"key": "9_CR74", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1111/j.1468-2982.2004.00738.x", "volume": "24", "author": "M Padberg", "year": "2004", "unstructured": "Padberg M, de Bruijn SF, de Haan RJ, Tavy DL. Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia. 2004;24:675\u201380.", "journal-title": "Cephalalgia"}, {"key": "9_CR75", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1016/j.pain.2004.01.016", "volume": "109", "author": "WJ Schulte-Mattler", "year": "2004", "unstructured": "Schulte-Mattler WJ, Krack P, BoNTTH Study Group. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study. Pain. 2004;109:110\u20134.", "journal-title": "Pain"}, {"key": "9_CR76", "unstructured": "Silberstein SD, G\u00f6bel H, Jensen R, Elkind AH, Degryse R, Walcott JM, Turkel C. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study. Cephalalgia. 2006;26:790\u2013800.", "DOI": "10.1111/j.1468-2982.2006.01114.x", "doi-asserted-by": "crossref"}, {"key": "9_CR77", "unstructured": "Straube A, Empl M, Ceballos-Baumann A, T\u00f6lle T, Stefenelli U, Pfaffenrath V. Dysport Tension-Type Headache Study Group. Pericranial injection of botulinum toxin type A (Dysport) for tension-type headache\u2014a multicentre, double-blind, randomized, placebo-controlled study. Eur J Neurol. 2008;15:205\u201313.", "DOI": "10.1111/j.1468-1331.2007.02051.x", "doi-asserted-by": "crossref"}, {"key": "9_CR78", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1007/s10194-008-0082-2", "volume": "10", "author": "SM Hamdy", "year": "2009", "unstructured": "Hamdy SM, Samir H, El-Sayed M, Adel N, Hasan R. Botulinum toxin: could it be an \u2018effective treatment for chronic tension-type headache? J Headache Pain. 2009;10:27\u201334.", "journal-title": "J Headache Pain"}, {"key": "9_CR79", "unstructured": "Harden RN, Cottrill J, Gagnon CM, Smitherman TA, Weinland SR, Tann B, Joseph P, Lee TS, Houle TT. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study. Headache. 2009;49:732\u201343.", "DOI": "10.1111/j.1526-4610.2008.01286.x", "doi-asserted-by": "crossref"}, {"key": "9_CR80", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1111/odi.12263", "volume": "22", "author": "M Eller", "year": "2016", "unstructured": "Eller M, Goadsby PJ. Trigeminal autonomic cephalalgias. Oral Dis. 2016;22:1\u20138.", "journal-title": "Oral Dis"}, {"key": "9_CR81", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1007/s11910-016-0641-x", "volume": "16", "author": "JA Ailani", "year": "2016", "unstructured": "Ailani JA. Practical approach to autonomic dysfunction in patients with headache. Curr Neurol Neurosci rep. 2016;16:41.", "journal-title": "Curr Neurol Neurosci rep"}, {"key": "9_CR82", "doi-asserted-by": "crossref", "first-page": "1079", "DOI": "10.1177/0333102414529672", "volume": "34", "author": "AS Petersen", "year": "2014", "unstructured": "Petersen AS, Barloese MC, Jensen RH. Oxygen treatment of cluster headache: a review. Cephalalgia. 2014;34:1079\u201387.", "journal-title": "Cephalalgia"}, {"key": "9_CR83", "doi-asserted-by": "crossref", "first-page": "1177", "DOI": "10.1517/14656566.2015.1040392", "volume": "16", "author": "M Obermann", "year": "2015", "unstructured": "Obermann M, Holle D, Naegel S, Burmeister J, Diener HC. Pharmacotherapy options forcluster headache. Expert Opin Pharmacother. 2015;16:1177\u201384.", "journal-title": "Expert Opin Pharmacother"}, {"key": "9_CR84", "doi-asserted-by": "crossref", "first-page": "438", "DOI": "10.1007/s11916-014-0438-z", "volume": "18", "author": "S Miller", "year": "2014", "unstructured": "Miller S, Matharu M. Trigeminal autonomic cephalalgias: beyond the conventional treatments. Curr Pain Headache Rep. 2014;18:438.", "journal-title": "Curr Pain Headache Rep"}, {"key": "9_CR85", "first-page": "883", "volume": "18", "author": "PJ Goadsby", "year": "2012", "unstructured": "Goadsby PJ. Trigeminal autonomic cephalalgias. Continuum. 2012;18:883\u201395.", "journal-title": "Continuum"}, {"key": "9_CR86", "unstructured": "Leone M., Proietti Cecchini A. Deep brain stimulation in headache. Cephalalgia 2015;36(12):1143\u20131148.", "DOI": "10.1177/0333102415607176", "doi-asserted-by": "crossref"}, {"key": "9_CR87", "doi-asserted-by": "crossref", "first-page": "236", "DOI": "10.1007/s10194-007-0400-0", "volume": "8", "author": "P Sostak", "year": "2007", "unstructured": "Sostak P, Krause P, F\u00f6rderreuther S, Reinisch V, Straube A. Botulinum toxin type-A therapy in cluster headache: an open study. J Headache Pain. 2007;8:236\u201341.", "journal-title": "J Headache Pain"}, {"key": "9_CR88", "unstructured": "Bratbak DF, Nordg\u00e5rd S, Stovner LJ, Linde M, Folvik M, Bugten V, Tronvik E. Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic cluster headache. Cephalalgia. 2016;36:503\u2013509.", "DOI": "10.1177/0333102415597891", "doi-asserted-by": "crossref"}, {"key": "9_CR89", "doi-asserted-by": "crossref", "first-page": "869", "DOI": "10.1177/0333102412452045", "volume": "32", "author": "RJ Zabalza", "year": "2012", "unstructured": "Zabalza RJ. Sustained response to botulinum toxin in SUNCT syndrome. Cephalalgia. 2012;32:869\u201372.", "journal-title": "Cephalalgia"}, {"key": "9_CR90", "unstructured": "Zhang Y, Zhang H, Lian, YJ, Ma YQ, Xie NC, Cheng X, Zhang L. Botulinum Toxin A for the treatment of a child with SUNCT syndrome. Pain Res Manag. 2016;2016, 8016065 [Epub ahead of print].", "DOI": "10.1155/2016/8016065", "doi-asserted-by": "crossref"}], "container-title": ["Botulinum Toxin Treatment in Clinical Medicine"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-56038-0_9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 2]], "date-time": "2019-10-02T18:00:30Z", "timestamp": 1570039230000}, "score": 25.991367, "issued": {"date-parts": [[2017, 8, 24]]}, "ISBN": ["9783319560373", "9783319560380"], "references-count": 90, "URL": "http://dx.doi.org/10.1007/978-3-319-56038-0_9", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T09:00:08Z", "timestamp": 1575190808917}, "publisher-location": "Berlin/Heidelberg", "reference-count": 36, "publisher": "Springer-Verlag", "isbn-type": [{"value": "3540230645", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1007/3-540-27333-6_5", "type": "book-chapter", "created": {"date-parts": [[2005, 12, 3]], "date-time": "2005-12-03T08:58:13Z", "timestamp": 1133600293000}, "page": "83-92", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Botulinum Toxin"], "prefix": "10.1007", "author": [{"given": "Cheryl M.", "family": "Burgess", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"issue": "5", "key": "5_CR1", "doi-asserted-by": "publisher", "first-page": "788", "DOI": "10.1016/S0190-9622(96)90016-X", "volume": "34", "author": "A. Carruthers", "year": "1996", "unstructured": "Carruthers A, Kiene K, Carruthers J (1996) Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol 34(5): 788\u2013797", "journal-title": "J Am Acad Dermatol"}, {"issue": "4", "key": "5_CR2", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1007/s11910-001-0087-6", "volume": "1", "author": "R. Tintner", "year": "2001", "unstructured": "Tintner R, Jankovic J (2001) Focal dystonia: the role of botulinum toxin. Curr Neurol Neurosci Rep 1(4): 337\u2013345", "journal-title": "Curr Neurol Neurosci Rep"}, {"issue": "4", "key": "5_CR3", "doi-asserted-by": "crossref", "first-page": "533", "DOI": "10.1001/archotol.126.4.533", "volume": "126", "author": "M.E. Smith", "year": "2000", "unstructured": "Smith ME, Ford CN (2000) Resistance to botulinum toxin injections for spasmodic dysphonia. Arch Otolaryngol Head Neck Surg 126(4): 533\u2013535", "journal-title": "Arch Otolaryngol Head Neck Surg"}, {"issue": "12", "key": "5_CR4", "doi-asserted-by": "crossref", "first-page": "1861", "DOI": "10.1016/S0161-6420(93)31384-9", "volume": "100", "author": "R.M. Siatkowski", "year": "1993", "unstructured": "Siatkowski RM et al (1993) Serum antibody production to botulinum A toxin. Ophthalmology 100(12): 1861\u20131866", "journal-title": "Ophthalmology"}, {"key": "5_CR5", "unstructured": "Elan Pharmaceutical Inc (2000) Myobloc package insert"}, {"key": "5_CR6", "unstructured": "Guttman C (2002) Botulinum toxin type B option for wrinkles, sweating. Dermatology Times"}, {"issue": "4", "key": "5_CR7", "doi-asserted-by": "crossref", "first-page": "618", "DOI": "10.1016/S0161-6420(96)30644-1", "volume": "103", "author": "J.A. Foster", "year": "1996", "unstructured": "Foster JA et al (1996) The use of botulinum A toxin to ameliorate facial kinetic frown lines. Ophthalmology 103(4): 618\u2013622", "journal-title": "Ophthalmology"}, {"issue": "12", "key": "5_CR8", "first-page": "924", "volume": "12", "author": "A.B. Scott", "year": "1973", "unstructured": "Scott AB, Rosenbaum A, Collins C (1973) Pharmacologic weakening of extraocular muscles. Invest Ophthalmol 12(12): 924\u2013927", "journal-title": "Invest Ophthalmol"}, {"issue": "7313", "key": "5_CR9", "doi-asserted-by": "publisher", "first-page": "596", "DOI": "10.1136/bmj.323.7313.596", "volume": "323", "author": "M. Naumann", "year": "2001", "unstructured": "Naumann M, Lowe NJ (2001) Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised parallel group double blind placebo controlled trial. BMJ 323(7313): 596\u2013599", "journal-title": "BMJ"}, {"issue": "6", "key": "5_CR10", "doi-asserted-by": "crossref", "first-page": "972", "DOI": "10.1097/00006534-199212000-00004", "volume": "90", "author": "G.E. Borodic", "year": "1992", "unstructured": "Borodic GE, Cheney M, McKenna M (1992) Contralateral injections of botulinum A toxin for the treatment of hemifacial spasm to achieve increased facial symmetry. Plast Reconstr Surg 90(6): 972\u2013979", "journal-title": "Plast Reconstr Surg"}, {"issue": "4", "key": "5_CR11", "doi-asserted-by": "publisher", "first-page": "569", "DOI": "10.1016/S0190-9622(96)90682-9", "volume": "35", "author": "N.J. Lowe", "year": "1996", "unstructured": "Lowe NJ, Maxwell A, Harper H (1996) Botulinum A exotoxin for glabellar folds: a double-blind placebocontrolled study with an electromyographic injection technique. J Am Acad Dermatol 35(4): 569\u2013572", "journal-title": "J Am Acad Dermatol"}, {"issue": "4", "key": "5_CR12", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1001/archoto.123.4.389", "volume": "123", "author": "A. Blitzer", "year": "1997", "unstructured": "Blitzer A et al (1997) The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients. Arch Otolaryngol Head Neck Surg 123(4): 389\u2013392", "journal-title": "Arch Otolaryngol Head Neck Surg"}, {"key": "5_CR13", "author": "P. Fodor", "year": "1996", "unstructured": "Fodor P, Nicanor GI, Hengst TC (1996) Endoscopically assisted plastic surgery. Mosby, St Louis", "volume-title": "Endoscopically assisted plastic surgery"}, {"key": "5_CR14", "unstructured": "Allergan Pharmaceuticals (2002) Botox Cosmetic (botulinum toxin type A). Prescribing information"}, {"key": "5_CR15", "author": "A. Carruthers", "first-page": "577", "year": "1994", "unstructured": "Carruthers A, Carruthers J (1994) Botulinum toxin used in the treatment of glabellar frown lines and other facial wrinkles. In: Jankovic J, Hallett M (eds) Therapy with botulinum toxin. Marcel Dekker, New York, pp 577\u2013595", "volume-title": "Therapy with botulinum toxin"}, {"key": "5_CR16", "unstructured": "Dysport Cbotulinum type A toxin-haemagglutinin complex: patient information leaflet"}, {"key": "5_CR17", "unstructured": "Elan Pharmaceuticals (2004) Myobloc: Cosmetic use"}, {"issue": "9", "key": "5_CR18", "doi-asserted-by": "publisher", "first-page": "817", "DOI": "10.1046/j.1524-4725.2002.02037.x", "volume": "28", "author": "N.S. Sadick", "year": "2002", "unstructured": "Sadick NS, Faacs (2002) Botulinum toxin type B for glabellar wrinkles: a prospective open-label response study. Dermatol Surg 28(9): 817\u2013821", "journal-title": "Dermatol Surg"}, {"issue": "5", "key": "5_CR19", "doi-asserted-by": "publisher", "first-page": "501", "DOI": "10.1046/j.1524-4725.2003.29122.x", "volume": "29", "author": "N.S. Sadick", "year": "2003", "unstructured": "Sadick NS (2003) Prospective open-label study of botulinum toxin type B (Myobloc) at doses of 2400 and 3000 U for the treatment of glabellar wrinkles. Dermatol Surg 29(5): 501\u2013507", "journal-title": "Dermatol Surg"}, {"issue": "1", "key": "5_CR20", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1080/14764170260030126", "volume": "4", "author": "J.M. Spencer", "year": "2002", "unstructured": "Spencer JM, Gordon M, Goldberg DJ (2002) Botulinum B treatment of the glabellar and frontalis regions: a dose response analysis. J Cosmet Laser Ther 4(1): 19\u201323", "journal-title": "J Cosmet Laser Ther"}, {"issue": "5", "key": "5_CR21", "doi-asserted-by": "publisher", "first-page": "459", "DOI": "10.1067/mhn.2002.124706", "volume": "126", "author": "A.L. Ramirez", "year": "2002", "unstructured": "Ramirez AL, Reeck J, Maas CS (2002) Botulinum toxin type B (MyoBloc) in the management of hyperkinetic facial lines. Otolaryngol Head Neck Surg 126(5): 459\u2013467", "journal-title": "Otolaryngol Head Neck Surg"}, {"issue": "5", "key": "5_CR22", "doi-asserted-by": "publisher", "first-page": "516", "DOI": "10.1046/j.1524-4725.2003.29123.x", "volume": "29", "author": "T.S.L. Alster", "year": "2003", "unstructured": "Alster TSL, Lupton J R (2003) Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A. Dermatol Surg 29(5): 516\u2013518", "journal-title": "Dermatol Surg"}, {"issue": "1", "key": "5_CR23", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1080/14764170260030117", "volume": "4", "author": "N.J. Lowe", "year": "2002", "unstructured": "Lowe NJ et al (2002) Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing. J Cosmet Laser Ther 4(1): 15\u201318", "journal-title": "J Cosmet Laser Ther"}, {"issue": "5", "key": "5_CR24", "doi-asserted-by": "publisher", "first-page": "519", "DOI": "10.1046/j.1524-4725.2003.29124.x", "volume": "29", "author": "T.C. Flynn", "year": "2003", "unstructured": "Flynn TC, Clark RE (2003) 2nd Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion. Dermatol Surg 29(5): 519\u2013522", "journal-title": "Dermatol Surg"}, {"issue": "5", "key": "5_CR25", "first-page": "508", "volume": "29", "author": "L. Baumann", "year": "2003", "unstructured": "Baumann L et al (2003) A double-blinded randomized placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B)-purified neurotoxin complex for the treatment of crow\u2019s feet: a double-blinded placebo-controlled trial. Dermatol Surg 29(5): 508\u2013515", "journal-title": "Dermatol Surg"}, {"issue": "1", "key": "5_CR26", "doi-asserted-by": "publisher", "first-page": "7", "DOI": "10.1046/j.1524-4725.2003.29017.x", "volume": "29", "author": "S.L. Matarasso", "year": "2003", "unstructured": "Matarasso SL (2003) Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides. Dermatol Surg 29(1): 7\u201313", "journal-title": "Dermatol Surg"}, {"issue": "9143", "key": "5_CR27", "doi-asserted-by": "publisher", "first-page": "1832", "DOI": "10.1016/S0140-6736(05)79896-2", "volume": "352", "author": "G. Borodic", "year": "1998", "unstructured": "Borodic G (1998) Myasthenic crisis after botulinum toxin Lancet 352(9143): 1832", "journal-title": "Lancet"}, {"issue": "11", "key": "5_CR28", "doi-asserted-by": "crossref", "first-page": "1235", "DOI": "10.1136/jnnp.56.11.1235", "volume": "56", "author": "F. Erbguth", "year": "1993", "unstructured": "Erbguth F et al (1993) Systemic effect of local botulinum toxin injections unmasks subclinical Lambert-Eaton myasthenic syndrome J Neurol Neurosurg Psychiatry 56(11): 1235\u20131236", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "5_CR29", "unstructured": "ATC Draft (2001) Facial aesthetic enhancements: chemodenervation and tissue augmentation pp 76"}, {"issue": "2", "key": "5_CR30", "first-page": "133", "volume": "3", "author": "J.C. Finn", "year": "2004", "unstructured": "Finn JC (2004) Botulinum toxin type A: fine-tuning treatment of facial nerve injury. J Drugs Dermatol 3(2): 133\u2013137", "journal-title": "J Drugs Dermatol"}, {"issue": "8", "key": "5_CR31", "doi-asserted-by": "publisher", "first-page": "703", "DOI": "10.1046/j.1524-4725.2001.01038.x", "volume": "27", "author": "T.C. Flynn", "year": "2001", "unstructured": "Flynn TC, Carruthers, JA (2001) Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye. Dermatol Surg 27(8): 703\u2013708", "journal-title": "Dermatol Surg"}, {"issue": "2", "key": "5_CR32", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1053/sder.2001.25139", "volume": "20", "author": "J. Carruthers", "year": "2001", "unstructured": "Carruthers J, Carruthers A (2001) BOTOX use in the mid and lower face and neck. Semin Cutan Med Surg 20(2): 85\u201392", "journal-title": "Semin Cutan Med Surg"}, {"issue": "2", "key": "5_CR33", "doi-asserted-by": "publisher", "first-page": "168", "DOI": "10.1046/j.1524-4725.2002.01116.x", "volume": "28", "author": "P.M. Becker-Wegerich", "year": "2002", "unstructured": "Becker-Wegerich PM, Rauch L, Ruzicka T (2002) Botulinum toxin A: successful d\u00e9collet\u00e9 rejuvenation. Dermatol Surg 28(2): 168\u2013171", "journal-title": "Dermatol Surg"}, {"issue": "4", "key": "5_CR34", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1002/mds.870030409", "volume": "3", "author": "A.B. Scott", "year": "1988", "unstructured": "Scott AB, Suzuki D (1988) Systemic toxicity of botulinum toxin by intramuscular injection in the monkey. Mov Disord 3(4): 333\u2013335", "journal-title": "Mov Disor"}, {"issue": "7", "key": "5_CR35", "doi-asserted-by": "publisher", "first-page": "672", "DOI": "10.1002/mus.880140711", "volume": "14", "author": "D.J. Lange", "year": "1991", "unstructured": "Lange DJ et al (1991) Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Muscle Nerve 14(7): 672\u2013675", "journal-title": "Muscle Nerve"}, {"issue": "9", "key": "5_CR36", "doi-asserted-by": "publisher", "first-page": "844", "DOI": "10.1136/jnnp.55.9.844", "volume": "55", "author": "P. Girlanda", "year": "1992", "unstructured": "Girlanda P et al (1992) Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system. J Neurol Neurosurg Psychiatry 55(9): 844\u2013845", "journal-title": "J Neurol Neurosurg Psychiatry"}], "container-title": ["Cosmetic Dermatology"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/3-540-27333-6_5", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 6]], "date-time": "2019-02-06T09:18:22Z", "timestamp": 1549444702000}, "score": 25.626371, "issued": {"date-parts": [[null]]}, "ISBN": ["3540230645"], "references-count": 36, "URL": "http://dx.doi.org/10.1007/3-540-27333-6_5", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T10:30:20Z", "timestamp": 1574505020779}, "reference-count": 6, "publisher": "SAGE Publications", "issue": "15", "license": [{"URL": "http://journals.sagepub.com/page/policies/text-and-data-mining-license", "start": {"date-parts": [[2012, 9, 18]], "date-time": "2012-09-18T00:00:00Z", "timestamp": 1347926400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["journals.sagepub.com"], "crossmark-restriction": true}, "short-container-title": ["Cephalalgia"], "published-print": {"date-parts": [[2012, 11]]}, "DOI": "10.1177/0333102412459577", "type": "journal-article", "created": {"date-parts": [[2012, 9, 19]], "date-time": "2012-09-19T06:59:08Z", "timestamp": 1348037948000}, "page": "1154-1155", "update-policy": "http://dx.doi.org/10.1177/sage-journals-update-policy", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Botulinum toxin for trigeminal neuralgia \u2013 do we have the evidence?"], "prefix": "10.1177", "volume": "32", "author": [{"given": "Joanna M", "family": "Zakrzewska", "sequence": "first", "affiliation": []}], "member": "179", "published-online": {"date-parts": [[2012, 9, 18]]}, "reference": [{"key": "bibr1-0333102412459577", "DOI": "10.1111/j.1600-0404.2011.01544.x", "doi-asserted-by": "publisher"}, {"key": "bibr2-0333102412459577", "DOI": "10.1177/0333102412441721", "doi-asserted-by": "publisher"}, {"key": "bibr3-0333102412459577", "DOI": "10.1136/bmj.c723", "doi-asserted-by": "publisher"}, {"key": "bibr4-0333102412459577", "DOI": "10.1136/bmj.c3803", "doi-asserted-by": "publisher"}, {"key": "bibr5-0333102412459577", "DOI": "10.1016/j.pain.2004.09.012", "doi-asserted-by": "publisher"}, {"key": "bibr6-0333102412459577", "DOI": "10.1097/WCO.0b013e328352c465", "doi-asserted-by": "publisher"}], "container-title": ["Cephalalgia"], "language": "en", "link": [{"URL": "http://journals.sagepub.com/doi/pdf/10.1177/0333102412459577", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/full-xml/10.1177/0333102412459577", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/pdf/10.1177/0333102412459577", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 31]], "date-time": "2019-01-31T11:19:52Z", "timestamp": 1548933592000}, "score": 25.333637, "issued": {"date-parts": [[2012, 9, 18]]}, "references-count": 6, "journal-issue": {"published-online": {"date-parts": [[2012, 9, 18]]}, "published-print": {"date-parts": [[2012, 11]]}, "issue": "15"}, "alternative-id": ["10.1177/0333102412459577"], "URL": "http://dx.doi.org/10.1177/0333102412459577", "relation": {"cites": []}, "ISSN": ["0333-1024", "1468-2982"], "issn-type": [{"value": "0333-1024", "type": "print"}, {"value": "1468-2982", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T20:18:29Z", "timestamp": 1574799509570}, "publisher-location": "Chichester, UK", "reference-count": 37, "publisher": "John Wiley & Sons, Ltd", "isbn-type": [{"value": "9781444338256", "type": "print"}, {"value": "9781118661833", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9781118661833.ch8", "type": "book-chapter", "created": {"date-parts": [[2017, 6, 24]], "date-time": "2017-06-24T02:41:10Z", "timestamp": 1498272070000}, "page": "109-119", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Reconstitution, Dilution, Diffusion, and Migration of Botulinum Toxin"], "prefix": "10.1002", "author": [{"given": "Murad", "family": "Alam", "sequence": "first", "affiliation": [{"name": "Professor and Vice-Chair, Department of Dermatology, Section of Cutaneous and Aesthetic Surgery, Departments of Dermatology; Otolaryngology, and Surgery, Northwestern University; Chicago USA"}]}, {"given": "Hayes B.", "family": "Gladstone", "sequence": "additional", "affiliation": [{"name": "Gladstone Clinic; San Ramon USA"}]}, {"given": "David M.", "family": "Ozog", "sequence": "additional", "affiliation": [{"name": "Henry Ford Hospital; Chair, Department of Dermatology; C.S. Livingood Chair in Dermatology; Director of Cosmetic Dermatology; Detroit MI USA"}]}], "member": "311", "published-online": {"date-parts": [[2017, 6, 23]]}, "reference": [{"key": "10.1002/9781118661833.ch8-BIB0001|c8-cit-0001", "doi-asserted-by": "crossref", "first-page": "407", "DOI": "10.1016/j.jaad.2005.06.011", "article-title": "Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases", "volume": "53", "author": "Cote", "year": "2005", "journal-title": "J Am Acad Dermatol"}, {"key": "10.1002/9781118661833.ch8-BIB0002|c8-cit-0002", "first-page": "220", "article-title": "Case reports: Potential foreign body emboli associated with botulinum toxin A injections", "volume": "6", "author": "Beer", "year": "2007", "journal-title": "J Drugs Dermatol"}, {"key": "10.1002/9781118661833.ch8-BIB0003|c8-cit-0003", "doi-asserted-by": "crossref", "first-page": "S65", "DOI": "10.1016/j.ajic.2007.10.007", "article-title": "Care Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings", "volume": "35", "author": "Siegel", "year": "2007", "journal-title": "Am J Infect Control"}, {"key": "10.1002/9781118661833.ch8-BIB0004|c8-cit-0004", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1016/j.jaad.2011.10.008", "article-title": "Recommendations and current practices for the reconstitution and storage of botulinum toxin type A", "volume": "67", "author": "Liu", "year": "2012", "journal-title": "J Am Acad Dermatol"}, {"key": "10.1002/9781118661833.ch8-BIB0005|c8-cit-0005", "first-page": "523", "article-title": "Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application", "volume": "29", "author": "Hexsel", "year": "2003", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch8-BIB0006|c8-cit-0006", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.1001/archfaci.10.4.273", "article-title": "Questioning the need to use Botox within 4 hours of reconstitution. A study of fresh vs 2-week-old Botox", "volume": "10", "author": "Yang", "year": "2008", "journal-title": "Arch Facial Plast Surg"}, {"key": "10.1002/9781118661833.ch8-BIB0007|c8-cit-0007", "first-page": "1328", "article-title": "Clinical efficacy of botulinum toxin type A reconstituted and refrigerated 1 week before its application in external canthus dynamic lines", "volume": "33", "author": "Lizarralde", "year": "2007", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch8-BIB0008|c8-cit-0008", "doi-asserted-by": "crossref", "first-page": "933", "DOI": "10.1111/j.1524-4725.2009.01158.x", "article-title": "Blind multicenter study of the efficacy and safety of injections of a commercial preparation of botulinum toxin type A reconstituted up to 15 days before injection", "volume": "35", "author": "Hexsel", "year": "2009", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch8-BIB0009|c8-cit-0009", "doi-asserted-by": "crossref", "first-page": "188", "DOI": "10.1007/s00266-006-0161-1", "article-title": "Reconstituted botulinum type A neurotoxin: clinical efficacy after long-term freezing before use", "volume": "31", "author": "Parsa", "year": "2007", "journal-title": "Aesth Plast Surg"}, {"key": "10.1002/9781118661833.ch8-BIB0010|c8-cit-0010", "doi-asserted-by": "crossref", "first-page": "272", "DOI": "10.1016/j.jaad.2006.01.019", "article-title": "Sterility assessment of multiple use botulinum A exotoxin vials: a prospective simulation", "volume": "55", "author": "Alam", "year": "2006", "journal-title": "J Am Acad Dermatol"}, {"key": "10.1002/9781118661833.ch8-BIB0011|c8-cit-0011", "doi-asserted-by": "crossref", "first-page": "995", "DOI": "10.1038/sj.eye.6702465", "article-title": "Microbial growth in vials of botulinum toxin following use in clinic", "volume": "21", "author": "Menon", "year": "2007", "journal-title": "Eye"}, {"key": "10.1002/9781118661833.ch8-BIB0012|c8-cit-0012", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1097/IOP.0b013e3181607475", "article-title": "Botox: shaken, not stirred", "volume": "24", "author": "Kazim", "year": "2008", "journal-title": "Ophthal Plast Reconstr Surg"}, {"key": "10.1002/9781118661833.ch8-BIB0013|c8-cit-0013", "doi-asserted-by": "crossref", "first-page": "530", "DOI": "10.1097/00042728-200305000-00016", "article-title": "Foam during reconstitution does not affect the potency of botulinum toxin type A", "volume": "29", "author": "de Almeida", "year": "2003", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch8-BIB0014|c8-cit-0014", "doi-asserted-by": "crossref", "first-page": "510", "DOI": "10.1001/archderm.138.4.510", "article-title": "Pain associated with injection of botulinum A exotoxin reconstituted using saline with and without preservative: a double-blind, randomized controlled trial", "volume": "38", "author": "Alam", "year": "2002", "journal-title": "Arch Dermatol"}, {"key": "10.1002/9781118661833.ch8-BIB0015|c8-cit-0015", "doi-asserted-by": "crossref", "first-page": "875", "DOI": "10.1067/mjd.2003.487", "article-title": "Reduction in injection pain with botulinum toxin type B further diluted using saline with preservative: a double-blind, randomized control trial", "volume": "48", "author": "Van Laborde", "year": "2003", "journal-title": "J Am Acad Dermatol"}, {"key": "10.1002/9781118661833.ch8-BIB0016|c8-cit-0016", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1007/s00266-004-0062-0", "article-title": "Evaluating effects of preservative-containing saline solution on pain perception during botulinum toxin type-A injections at different locations: a prospective, single-blinded, randomized control trial", "volume": "29", "author": "Sarifakioglu", "year": "2005", "journal-title": "Aesth Plast Surg"}, {"key": "10.1002/9781118661833.ch8-BIB0017|c8-cit-0017", "doi-asserted-by": "crossref", "first-page": "1S", "DOI": "10.1097/01.PRS.0000144795.76040.D3", "article-title": "Botox Consensus Group. Consensus recommendations on the use of botulinum toxin type a in facial aesthetics", "volume": "114", "author": "Carruthers", "year": "2004", "journal-title": "Plast Reconstr Surg"}, {"key": "10.1002/9781118661833.ch8-BIB0018|c8-cit-0018", "doi-asserted-by": "crossref", "first-page": "186", "DOI": "10.1097/01.IOP.0000129012.09632.49", "article-title": "Increased patient comfort utilizing botulinum toxin type A reconstituted with preserved saline versus nonpreserved saline", "volume": "20", "author": "Kwiat", "year": "2004", "journal-title": "Ophthal Plast Reconstr Surg"}, {"key": "10.1002/9781118661833.ch8-BIB0019|c8-cit-0019", "doi-asserted-by": "crossref", "first-page": "986", "DOI": "10.1111/j.1365-2133.2007.07760.x", "article-title": "Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study", "volume": "156", "author": "Vadoud-Seyedi", "year": "2007", "journal-title": "Br J Dermatol"}, {"issue": "7", "key": "10.1002/9781118661833.ch8-BIB0020|c8-cit-0020", "first-page": "886", "article-title": "Pain sensation during intradermal injections of three different botulinum toxin preparations in different doses and dilutions", "volume": "32", "author": "Kranz", "year": "2006", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch8-BIB0021|c8-cit-0021", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1080/14764170701883660", "article-title": "The five D's of botulinum toxin: doses, dilution, diffusion, duration, and dogma", "volume": "10", "author": "De Sa Earp", "year": "2008", "journal-title": "J Cosmet Laser Ther"}, {"key": "10.1002/9781118661833.ch8-BIB0022|c8-cit-0022", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1097/IOP.0b013e31819946c4", "article-title": "High versus low concentration botulinum toxin A for benign essential blepharospasm: does dilution make a difference", "volume": "25", "author": "Boyle", "year": "2009", "journal-title": "Ophthal Plast Reconstr Surg"}, {"key": "10.1002/9781118661833.ch8-BIB0023|c8-cit-0023", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1080/14764170802094282", "article-title": "Confusion about diffusion and the art of misinterpreting data when comparing different botulinum toxins used in aesthetic applications", "volume": "10", "author": "Pickett", "year": "2008", "journal-title": "J Cosmet Laser Ther"}, {"key": "10.1002/9781118661833.ch8-BIB0024|c8-cit-0024", "doi-asserted-by": "crossref", "first-page": "1351", "DOI": "10.1001/archderm.140.11.1351", "article-title": "Effect of volume and concentration on the diffusion of botulinum exotoxin A", "volume": "140", "author": "Hsu", "year": "2004", "journal-title": "Arch Dermatol"}, {"key": "10.1002/9781118661833.ch8-BIB0025|c8-cit-0025", "doi-asserted-by": "crossref", "first-page": "S97", "DOI": "10.1111/j.1524-4725.2006.32339.x", "article-title": "Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter", "volume": "33", "author": "Carruthers", "year": "2007", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch8-BIB0026|c8-cit-0026", "first-page": "567", "article-title": "A randomized, evaluator-blinded, two-center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type A in the treatment of lateral orbital rhytides", "volume": "33", "author": "Carruthers", "year": "2007", "journal-title": "Dermatol Surg"}, {"issue": "Suppl 1", "key": "10.1002/9781118661833.ch8-BIB0027|c8-cit-0027", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1080/17429590701523794", "article-title": "Diffusion characteristics of botulinum neurotoxin products and their clinical significance in cosmetic applications", "volume": "9", "author": "de Almeida", "year": "2007", "journal-title": "J Cosmet Laser Ther"}, {"key": "10.1002/9781118661833.ch8-BIB0028|c8-cit-0028", "doi-asserted-by": "crossref", "first-page": "S37", "DOI": "10.1111/j.1524-4725.2006.32330.x", "article-title": "Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis", "volume": "33", "author": "de Almeida", "year": "2007", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch8-BIB0029|c8-cit-0029", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1007/s00403-011-1179-z", "article-title": "Comparison of the spread of three botulinum toxin type A preparations", "volume": "304", "author": "Kerscher", "year": "2012", "journal-title": "Arch Dermatol Res"}, {"key": "10.1002/9781118661833.ch8-BIB0030|c8-cit-0030", "doi-asserted-by": "crossref", "first-page": "52", "DOI": "10.1097/00042728-200801000-00009", "article-title": "A randomized pilot study comparing the action halos of two commercial preparations of botulinum toxin type A", "volume": "34", "author": "Hexsel", "year": "2008", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch8-BIB0031|c8-cit-0031", "first-page": "519", "article-title": "Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion", "volume": "29", "author": "Flynn", "year": "2003", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch8-BIB0032|c8-cit-0032", "doi-asserted-by": "crossref", "first-page": "176", "DOI": "10.1111/j.1365-2133.2010.10085.x", "article-title": "Long-term efficacy and respective potencies of botulinum toxin A and B: a randomized, double-blind study", "volume": "164", "author": "Kranz", "year": "2011", "journal-title": "Br J Dermatol"}, {"key": "10.1002/9781118661833.ch8-BIB0033|c8-cit-0033", "first-page": "229", "article-title": "Anhidrotic effect of intradermal injections of botulinum toxin: a comparison of different products and concentrations", "volume": "88", "author": "Rystedt", "year": "2008", "journal-title": "Acta Derm Venereol"}, {"key": "10.1002/9781118661833.ch8-BIB0034|c8-cit-0034", "doi-asserted-by": "crossref", "first-page": "458", "DOI": "10.2340/00015555-0490", "article-title": "Equipotent concentrations of Botox and Dysport in the treatment of palmar hyperhidrosis", "volume": "88", "author": "Rystedt", "year": "2008", "journal-title": "Acta Derm Venereol"}, {"key": "10.1002/9781118661833.ch8-BIB0035|c8-cit-0035", "doi-asserted-by": "crossref", "first-page": "218", "DOI": "10.1080/14764170310021841", "article-title": "Botulinum toxin dilution: our technique", "volume": "5", "author": "Redaelli", "year": "2003", "journal-title": "J Cosmet Laser Ther"}, {"key": "10.1002/9781118661833.ch8-BIB0036|c8-cit-0036", "first-page": "461", "article-title": "A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides", "volume": "33", "author": "Hantash", "year": "2007", "journal-title": "Dermatol Surg"}, {"key": "10.1002/9781118661833.ch8-BIB0037|c8-cit-0037", "first-page": "533", "article-title": "Diffusion and short-term efficacy of botulinum toxin A after the addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosis", "volume": "29", "author": "Goodman", "year": "2003", "journal-title": "Dermatol Surg"}], "container-title": ["Botulinum Toxins"], "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F9781118661833.ch8", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1002/9781118661833.ch8/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 9, 18]], "date-time": "2017-09-18T11:29:04Z", "timestamp": 1505734144000}, "score": 25.292892, "issued": {"date-parts": [[2017, 6, 23]]}, "ISBN": ["9781118661833", "9781444338256"], "references-count": 37, "URL": "http://dx.doi.org/10.1002/9781118661833.ch8", "relation": {"cites": []}}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}